Neuroendocrine-immune homeostasis in health and disease is a tightly regulated bidirectional network that influences predisposition, onset and progression of age-associated disorders. The complexity of interactions among the nervous, endocrine and immune systems necessitates a complete review of all the likely mechanisms by which each individual system can alter neuroendocrine-immune homeostasis and influence the outcome in age and disease. Dysfunctions in this network with age or external/internal stimuli are implicated in the development of several disorders including autoimmunity and cancer. The existence of sympathetic noradrenergic innervations on lymphoid organs in synaptic association with immune cells that express receptors for endocrine mediators such as hormones, neural mediators such as neurotransmitters and immune effector molecules such as cytokines explains the complicated nature of the regulatory pathways that must always maintain homeostatic equilibrium within and among the nervous, endocrine and immune systems. The incidence, development and progression of cancer, affects each of the three systems by disrupting regulatory pathways and tipping the scales away from homeostasis to favour pathways that enable it to evade, override and thrive by using the network to its advantage. In this review, we have explained how the neuroendocrine-immune network is altered in female reproductive aging and cancer, and how these modulations contribute to incidence and progression of cancer and hence prove to be valuable targets from a therapeutic standpoint. Reproductive aging, stress-associated central pathways, sympathetic immunomodulation in the periphery, inflammatory and immunomodulatory changes in central, peripheral and tumor-microenvironment, and neuro-neoplastic associations are all likely candidates that influence the onset, incidence and progression of cancer.
Citation: Hannah P. Priyanka, Rahul S. Nair, Sanjana Kumaraguru, Kirtikesav Saravanaraj, Vasantharekha Ramasamy. Insights on neuroendocrine regulation of immune mediators in female reproductive aging and cancer[J]. AIMS Molecular Science, 2021, 8(2): 127-148. doi: 10.3934/molsci.2021010
[1] | Vasudeva Reddy Tatiparthi, Madhava Rao, Santosh Kumar, Hindumathi . Detection and analysis of coagulation effect in vein using MEMS laminar flow for the early heart stroke diagnosis. AIMS Bioengineering, 2023, 10(1): 1-12. doi: 10.3934/bioeng.2023001 |
[2] | Wagner C. A. Carvalho, Rayane A. S. Freitas, Milson S. Barbosa, Ariela V. Paula, Ernandes B. Pereira, Adriano A. Mendes, Elton Franceschi, Cleide M. F. Soares . Preparation and characterization of new silica-based heterofunctional biocatalysts utilizing low-cost lipase Eversa® Transform 2.0 and evaluation of their catalytic performance in isoamyl esters production from Moringa oleifera Lam oil. AIMS Bioengineering, 2024, 11(2): 185-211. doi: 10.3934/bioeng.2024011 |
[3] | Bennet Brockhagen, Fabian Schoden, Jan Lukas Storck, Timo Grothe, Christian Eßelmann, Robin Böttjer, Anke Rattenholl, Frank Gudermann . Investigating minimal requirements for plants on textile substrates in low-cost hydroponic systems. AIMS Bioengineering, 2021, 8(2): 173-191. doi: 10.3934/bioeng.2021016 |
[4] | Mee-Hae Kim, Masakazu Inamori, Masakazu Akechi, Hirohisa Abe, Yoshiki Yagi, Masahiro Kino-oka . Development of an automated chip culture system with integrated on-line monitoring for maturation culture of retinal pigment epithelial cells. AIMS Bioengineering, 2017, 4(4): 402-417. doi: 10.3934/bioeng.2017.4.402 |
[5] | Natalia Fullana, Victoria Braña, Juan José Marizcurrena, Danilo Morales, Jean-Michel Betton, Mónica Marín, Susana Castro-Sowinski . Identification, recombinant production and partial biochemical characterization of an extracellular cold-active serine-metalloprotease from an Antarctic Pseudomonas isolate. AIMS Bioengineering, 2017, 4(3): 386-401. doi: 10.3934/bioeng.2017.3.386 |
[6] | Torsten Schüling, Alina Eilers, Thomas Scheper, Johanna Walter . Aptamer-based lateral flow assays. AIMS Bioengineering, 2018, 5(2): 78-102. doi: 10.3934/bioeng.2018.2.78 |
[7] | Yingyu Law, Leo Wein . Reversing the nutrient drain through urban insect farming—opportunities and challenges. AIMS Bioengineering, 2018, 5(4): 226-237. doi: 10.3934/bioeng.2018.4.226 |
[8] | Daniel Borchert, Diego A. Suarez-Zuluaga, Yvonne E. Thomassen, Christoph Herwig . Risk assessment and integrated process modeling–an improved QbD approach for the development of the bioprocess control strategy. AIMS Bioengineering, 2020, 7(4): 254-271. doi: 10.3934/bioeng.2020022 |
[9] | Yong-Qiang Liu, Sri Suhartini, Liang Guo, Yeping Xiong . Improved biological wastewater treatment and sludge characteristics by applying magnetic field to aerobic granules. AIMS Bioengineering, 2016, 3(4): 412-424. doi: 10.3934/bioeng.2016.4.412 |
[10] | Jingwen Zhang, Lu Wang, Huolin Chen, Tieying Yin, Yanqun Teng, Kang Zhang, Donghong Yu, Guixue Wang . Effect of Caspase Inhibitor Ac-DEVD-CHO on Apoptosis of Vascular Smooth Muscle Cells Induced by Artesunate. AIMS Bioengineering, 2014, 1(1): 13-24. doi: 10.3934/bioeng.2014.1.13 |
Neuroendocrine-immune homeostasis in health and disease is a tightly regulated bidirectional network that influences predisposition, onset and progression of age-associated disorders. The complexity of interactions among the nervous, endocrine and immune systems necessitates a complete review of all the likely mechanisms by which each individual system can alter neuroendocrine-immune homeostasis and influence the outcome in age and disease. Dysfunctions in this network with age or external/internal stimuli are implicated in the development of several disorders including autoimmunity and cancer. The existence of sympathetic noradrenergic innervations on lymphoid organs in synaptic association with immune cells that express receptors for endocrine mediators such as hormones, neural mediators such as neurotransmitters and immune effector molecules such as cytokines explains the complicated nature of the regulatory pathways that must always maintain homeostatic equilibrium within and among the nervous, endocrine and immune systems. The incidence, development and progression of cancer, affects each of the three systems by disrupting regulatory pathways and tipping the scales away from homeostasis to favour pathways that enable it to evade, override and thrive by using the network to its advantage. In this review, we have explained how the neuroendocrine-immune network is altered in female reproductive aging and cancer, and how these modulations contribute to incidence and progression of cancer and hence prove to be valuable targets from a therapeutic standpoint. Reproductive aging, stress-associated central pathways, sympathetic immunomodulation in the periphery, inflammatory and immunomodulatory changes in central, peripheral and tumor-microenvironment, and neuro-neoplastic associations are all likely candidates that influence the onset, incidence and progression of cancer.
The classical hyperbolic-parabolic system of the compressible Navier-Stokes (CNS) equations has been subject to a hyperbolization via a relaxation ansatz. The latter — known for classical heat conduction ever since Maxwell [1] in the 19th century or Cattaneo [2] in the 20th century introduced in order to avoid the phenomenon of infinite speed of propagation inherent in classical modeling of heat conduction — turns the system into a hyperbolic one. In view of the nonlinear character of CNS equations, the question of a possible blow-up of the solution is raised, since, roughly speaking, nonlinear hyperbolic systems tend to generate blow-ups in comparison to the corresponding parabolic ones. Here, corresponding means that the hyperbolized systems are characterized by a relaxation parameter τ>0, and formally turn into the original parabolic one for τ=0. See the linear example: the standard heat equation
θt+divq=0,q+∇θ=0, |
with temperature θ and heat flux q, leading to
θt−Δθ=0, |
turns with the relaxed/hyperbolized model
θt+divq=0,τqt+q+∇θ=0, |
into
τθtt+θt−Δθ=0. |
Naturally, the singular limit as τ→0 is of interest, in particular for the nonlinear CNS equations to be discussed.
We will consider the following fully or partly hyperbolized models for compressible Navier-Stokes systems with heat conduction.
Model 1: ([3])
First, relaxing only in the heat conduction as above, we have in Rn×[0,∞)(n=1,2,3)
{∂tρ+div(ρu)=0,∂t(ρu)+div(ρu⊗u)+∇p=divS,∂t(ρ(e+12u2))+div(ρu(e+12u2)+up)+divq=div(uS), | (1.1) |
where ρ, u=(u1,u2,⋯,un), p, S, e, and q represent fluid density, velocity, pressure, stress tensor, specific internal energy per unit mass, and heat flux, respectively. The equations (1.1)1, (1.1)2, and (1.1)3 are the consequence of conservation of mass, momentum, and energy, respectively. To complete the system (1.1), we need to impose constitutive assumptions on p, S, e, and q. First, we assume the fluid to be a Newtonian fluid, that is,
S=μ(∇u+∇uT−2ndivuIn)+λdivuIn, | (1.2) |
where μ and λ are positive constants. The heat flux q is assumed to satisfy
τ∂tq+q+κ∇θ=0, | (1.3) |
which represents Cattaneo's law (Maxwell's law, …), and where θ denotes the absolute temperature. The pressure p=p(ρ,θ) and e=e(ρ,θ) satisfy
ρ2eρ(ρ,θ)=p(ρ,θ)−θpθ(ρ,θ). | (1.4) |
In particular, the case of a polytropic gas p=Rρθ, e=cvθ is included here.
For the limit case τ=0, the system (1.1)–(1.3) is exactly the system of classical compressible Navier-Stokes equations, in which the relation between the heat flux and the temperature is governed by Fourier's law,
q=−κ∇θ. | (1.5) |
The well-posed theory has been widely studied for the system (1.1), (1.2) combined with Fourier's law (1.5), see [4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]. In particular, the local existence and uniqueness of smooth solutions was established by Serrin [17] and Nash [16] for initial data far away from a vacuum. Later, Matsumura and Nishida [14] got global smooth solutions for small initial data without a vacuum. For large data, Xin [18], and Cho and Jin [4], showed that smooth solutions must blow up in finite time if the initial data has a vacuum state.
Although Fourier's law plays an important role in experimental and applied physics, it has the drawback of an inherent infinite propagation speed of signals. Cattaneo's (Maxwell's) law has been widely used in thermoelasticity which results in the second sound phenomenon, see [19,20,21] and the references cited therein. Note that it is not obvious that the results which hold for Fourier's law also hold for Cattaneo's law. Indeed, and for example, Fernández Sare and Racke [22] showed that, for certain Timoshenko-type thermoelastic system, Fourier's law preserves the property of exponential stability while Cattaneo's law destroys such a property.
Model 2: ([23])
Instead of relaxing in the heat equation as in Model 1, we take Fourier's law for the heat flux, but now Maxwell's relaxation for the stress tensor S, which replaces (1.2) by the differential equation
τ∂tS+S=μ(∇u+∇uT−2ndivuIn)+λdivuIn. | (1.6) |
Here we will discuss a splitting of the tensor S, which was discussed by Yong [24] in the isentropic case leading to the following system with a revised Maxwell law, now for the non-isentropic case, that we are going to further investigate further.
{∂tρ+div(ρu)=0,∂t(ρu)+div(ρu⊗u)+∇p=div(S1)+∇S2,∂t(ρ(e+12u2))+div(ρu(e+12u2)+up)−κ△θ=div(u(S1+S2In)),τ1∂tS1+S1=μ(∇u+∇uT−2ndivuIn),τ2∂tS2+S2=λdivu, | (1.7) |
where S1 is an n×n square matrix, symmetric and traceless if it was initially, and S2 is a scalar variable.
Pelton, Chakraborty, Malachosky, Guyot-Sionnest, and Sader [25] showed that such a "time lag", represented by τ1,τ2>0, cannot be neglected, even for simple fluids, in the experiments of high-frequency vibration of nano-scale mechanical devices immersed in water-glycerol mixtures. A similar revised Maxwell model was considered by Chakraborty and Sader [26] for a compressible viscoelastic fluid (isentropic case), where τ1 counts for the shear relaxation time, and τ2 counts for the compressional relaxation time. The importance of this model for describing high-frequency limits is underlined together with the presentation of numerical experiments. The authors conclude that it provides a general formalism to characterize the fluid-structure interaction of nanoscale mechanical devices vibrating in simple liquids.
Model 3: ([27])
Considering the two relaxations from Model 1 (resp., Model 2) in one space dimension simultaneously, and, additionally, reflecting Galilean invariance in the constitutive equations for these, we look at
{ρt+(ρu)x=0,ρut+ρuux+px=Sx,ρet+ρuex+pux+qx=Sux, | (1.8) |
with
τ1(qt+uqx)+q+κθx=0, | (1.9) |
proposed by Christov and Jordan [28], and
τ2(St+uSx)+S=μux. | (1.10) |
Addtionally we specify the constitutive assumptions to
e=Cvθ+τ1κθρq2+τ22μρS2, | (1.11) |
p=Rρθ−τ12κθq2−τ22μS2, | (1.12) |
with positive constants Cv,R denoting the heat capacity at constant volume and the gas constant, respectively, such that they satisfy the thermodynamic equation (1.4). The dependence of the internal energy on q2 is indicated by Coleman, Fabrizio, and Owen [29], where they rigorously prove that for heat equations with Cattaneo-type law, the formulation (1.20) is consistent with the second law of thermodynamics, see also [30,31,32].
Model 4: ([33])
For the results in dimensions n=2,3 having two relaxations, we consider the specialized model
{∂tρ+div(ρu)=0,ρ∂tu+ρu⋅∇u+∇p=μdiv(∇u+∇uT−2ndivuIn)+∇S2,ρ∂te+ρu⋅∇e+pdivu+divq=μ(∇u+(∇u)T−2ndivuIn):∇u+S2divu,τ1(∂tq+u⋅∇q)+q+κ∇θ=0,τ3(∂tS2+u⋅∇S2)+S2=λdivu, | (1.13) |
where we have taken τ2=0 in (1.7). That is, we do not have a relaxation in S1. This case seems to be mathematically not yet accessible, even locally. For the blow-up result in Section 4, we restrict the considerations to the limiting case μ=0. This restriction is not only motivated because it is mathematically accessible with respect to local existence and blow-up, but also with a physical background. In fact, there are recent studies determining the volume viscosity of a variety of gases which were found to be much larger (factor 104) than the corresponding shear viscosities, see [34]. For the blow-up result, we specify the constitutive equations,
e=Cvθ+τ1κρθq2+τ32λρS22, | (1.14) |
p=Rρθ−τ12κθq2−τ32λS22. | (1.15) |
Model 5: ([35])
For the second blow-up result in one space dimension, we modify Model 3, which was the basis for the first blow-up result, as follows.
{ρt+(ρu)x=0,ρut+ρuux+px=Sx,Et+(uE+pu+q−Su)x=0, | (1.16) |
where E represents the total energy,
τ1(θ)(ρqt+ρu⋅qx)+q+κ(θ)θx=0, | (1.17) |
and
τ2(ρSt+ρu⋅Sx)+S=μux. | (1.18) |
The constitutive equation (1.18) was proposed by Freistühler [36,37] for the isentropic case, see also Ruggeri [38] and Müller [39] for a similar model in the non-isentropic case.
Furthermore, we assume that the energy is given by
E=12ρu2+τ22μρS2+ρe(θ,q), | (1.19) |
and the specific internal energy e and the pressure p are given by
e(θ)=Cvθ+a(θ)q2,p(ρ,θ)=Rρθ, | (1.20) |
where
a(θ)=Z(θ)θ−12Z′(θ)withZ(θ)=τ1(θ)κ(θ). |
The paper is organized as follows. In Section 2, we will recall results on the local well-posedness, small data global well-posedness, and the singular limit in finite time intervals. In Sections 3, 4, and 5, we will present blow-up results for one- and multi-dimensional models. Using ideas and techniques of Sideris from the 1980s [40,41], the blow-up for some of the models above will be demonstrated by studying appropriate functionals that satisfy differential inequalities implying a blow-up of smooth solutions in finite time.
We introduce some notation. Wm,p=Wm,p(Rn),0≤m≤∞,1≤p≤∞, denotes the usual Sobolev space with norm ‖⋅‖Wm,p. Hm and Lp stand for Wm,2(Rn) and W0,p(Rn), respectively.
Here, results on local well-posedness, on global well-posedness for small data, and on the singular limit τ↓0 are presented for the Models 1–5. In addition to the governing differential equations, we always need initial conditions.
Starting with Model 1 with differential equations (1.1)–(1.3), we have the initial conditions
(ρ(x,0),u(x,0),θ(x,0),q(x,0))=(ρ0,u0,θ0,q0). | (2.1) |
● Assumption A.1. The initial data satisfy
{(ρ0,u0,θ0,q0)(x):x∈Rn}⊂[ρ∗,ρ∗]×[−C1,C1]n×[θ∗,θ∗]×[−C1,C1]n=:G0, |
where C1>0 as well as 0<ρ∗<1<ρ∗<∞ and 0<θ∗<1<θ∗<∞ are constants.
● Assumption A.2. Let G:=R+×Rn×R+×Rn denote the physical state space. For each given G1 satisfying G0⊂⊂G1⊂⊂G, and for all (ρ,u,θ,q)∈G1, the pressure p and the internal energy e satisfy
p(ρ,θ),pθ(ρ,θ),pρ(ρ,θ),eθ(ρ,θ)>C(G1)>0, | (2.2) |
where C(G1) is a positive constant depending on G1.
Under these assumptions we have
Theorem 2.1 ([3]). Let n≥1 and s≥s0+1, with s0≥[n2]+1, be integers. Suppose that the assumptions A.1 and A.2 hold and that the initial data (ρ0−1,u0,θ0−1,q0) are in Hs. Then, for each convex open subset G1 satisfying G0⊂⊂G1⊂⊂G, there exists T>0 such that the system (1.1), (1.3), (2.1) has a unique classical solution (ρτ,uτ,θτ,qτ) satisfying
(ρτ−1,θτ−1,qτ)∈C([0,T],Hs)∩C1([0,T],Hs−1),uτ∈C([0,T],Hs)∩C1([0,T],Hs−2) | (2.3) |
and
(ρτ,uτ,θτ,qτ)(x,t)∈G1,∀(x,t)∈Rn×[0,T]. |
We write the system (1.1) as a symmetric hyperbolic-parabolic system for for ω:=(ρ,u,θ,q),
A0(ω)∂tω+Σnj=1Aj(ω)∂xjω−Σnj=1Bjk(ω)∂2xjxkω+L(ω)ω=g(ω,Dxω), | (2.4) |
where
A0(ω)=(c2ρ0000ρIn0000ρeθθ0000τκθ),Σnj=1Ajξj=(c2ρu⋅ξc2ξ00c2ξTρ(u⋅ξ)InpθξT00pθξρeθθu⋅ξξθ00ξTθ0),Σnj=1Bjkξjξk=(00000μIn+(μ+μ′)ξTξ0000000000),L(ω)=(0000000000000001κθIn),g(ω,Dxω)=(00μ2θ|∇u+(∇u)T|2+μ′θ|divu|20),c2=pρ,ξ=(ξ1,⋯,ξn)∈Sn−1. |
The local existence theorem now follows from [42] (or see [43]). As the global existence result for small data, we have:
Theorem 2.2 ([3]). Let n≥2 and s≥s0+1, with s0≥[n2]+1, be integers. Suppose that 0<τ<2κpθ(1,1)2 and (ρ0−1,u0,θ0−1,q0)∈Hs. Then there exists a positive constant δ such that if ‖(ρ0−1,u0,θ0−1,q0)‖s≤δ, then there exists a global unique solution (ρτ,uτ,θτ,qτ) of (1.1), (1.3), (2.1) satisfying
(ρτ−1,θτ−1,qτ)∈C([0,∞),Hs)∩C1([0,∞),Hs−1),uτ∈C([0,∞),Hs)∩C1([0,∞,Hs−2). | (2.5) |
For the proof, one linearizes the above system around the steady state ˉω=(ˉρ,ˉu,ˉθ,ˉq):=(1,0,1,0), and one has
A0(ˉω)∂tω+ΣAj(ˉω)∂xjω−ΣBjk(ˉω)∂2xjxkω+L(ˉω)ω=0, | (2.6) |
where
A0(ˉω)=(ˉc20000In0000ˉeθ0000τκ),ΣAj(ˉω)ξj=(0ˉc2ξ00ˉc2ξT0ˉpθξT00ˉpθξ0ξ00ξT0),ΣBjk(ˉω)ξjξk=(00000μIn+(μ+μ′)ξTξ0000000000),L(ˉω)=(0000000000000001κIn),ˉc=c(1,1),ˉpθ=pθ(1,1),ˉeθ=eθ(1,1),ξ=(ξ1,ξ2,⋯,ξn)∈Sn−1. |
We choose Kj such that
ΣKjξj=α(0ˉc2ξ00−ξT000000κτξ00−ξTeθ0), |
where α>0 will be chosen later. In order to satisfy the Kawashima conditions from [42], for proving the global existence for small data, one has to check that
12Σ{KjAkξjξk+(KjAkξjξk)T}+ΣBjkξjξk+L=(αˉc4012αˉpθˉc200μIn+((μ+μ′)−αˉc2)ξTξ0−αˉpθ2ˉeθξTξ12αˉpθˉc20ακτ00−αˉpθ2ˉeθξTξ01κIn−α1ˉeθξTξ) |
is a positive definite matrix for any ξ∈Sn−1, which holds true for sufficiently small α.
To show the convergence of the relaxed system (τ>0) to the classical CNS equations (τ=0), we assume the natural compatibility condition q0=−κ∇θ0. Let G1 be given satisfying G0⊂⊂G1⊂⊂G. Define Tτ=sup{T>0;(ρτ−1,vτ,θτ−1,qτ)∈C([0,T],Hs),(ρτ,vτ,θτ,qτ)(x,t)∈G1,∀(x,t)∈Rn×[0,T]}.
Theorem 2.3 ([3]). Let (ρ,u,θ) be a smooth solution to the classical compressible Navier-Stokes equations with (ρ(x,0),u(x,0),θ(x,0))=(ρ0,u0,θ0) satisfying
ρ∈C([0,T∗],Hs+3)∩C1([0,T∗],Hs+2),(u,θ)∈C([0,T∗],Hs+3)∩C1([0,T∗],Hs+1) |
with T∗>0 finite. Then there are positive constants τ0 and C such that for τ≤τ0,
‖(ρτ,uτ,θτ)(t,⋅)−(ρ,u,θ)(t,⋅)‖s≤Cτ | (2.7) |
and
‖(qτ+κ∇θ)(t,⋅)‖s≤Cτ12 | (2.8) |
for t∈[0,min{T∗,Tτ}), where C does not depend on τ. In particular, Tτ is independent of τ.
For the proof, we introduce the variable q:=−κ∇θ and define
ρd:=ρτ−ρτ,ud=uτ−uτ,θd=θτ−θτ,qd=qτ−qτ. | (2.9) |
Lengthy energy estimates give, for small τ and for t<min{T∗,Tτ},
‖(ρd,ud,θd)(t,⋅)‖s≤C,‖√τqd(t,⋅)‖s≤C, | (2.10) |
where C>0 denotes constants not depending on τ or t.
Looking at Model 2 with differential equations (1.7), we have the initial conditions
(ρ(x,0),u(x,0),θ(x,0),S1(x,0),S2(x,0))=(ρ0,u0,θ0,S10,S20)). | (2.11) |
Assumptions analogous to Assumptions A.1 and A.2 in (2.2) are assumed to hold. Then we have the following local existence theorem.
Theorem 2.4 ([23]). Let s≥s0+1 with s0≥[n2]+1 be integers. Suppose that the initial data (ρ0−1,u0,θ0−1,S10,S20) are in Hs. Then, for each convex open subset G1 satisfying G0⊂⊂G1⊂⊂G, there exists Tex>0 such that the system (1.7), (2.11) has a unique classical solution (ρ,u,θ,S1,S2) satisfying
{(ρ−1,u,S1,S2)∈C([0,Tex],Hs)∩C1([0,Tex],Hs−1),θ−1∈C([0,Tex],Hs)∩C1([0,Tex],Hs−2) | (2.12) |
and
(ρ,u,θ,S1,S2)(x,t)∈G1,∀(x,t)∈Rn×[0,Tex]. |
For the proof, a similar strategy as in the proof of Theorem 2.1 in Model 1 is applicable, i.e., transforming, after linearizing around a constant state, the system to a symmetric hyperbolic-parabolic one. In the two-dimensional case n=2, one can easily check that the system can be written in a symmetric form immediately, while in the 3-d case one needs further transformations to get a system in a symmetric form, see [23].
Using the explicit symmetrizer, one can check Kawashima's conditions, yielding the following global existence theorem for small data.
Theorem 2.5 ([23]). Let s≥s0+1 with s0≥[n2]+1 be integers. Suppose that the initial data satisfy (ρ0−1,u0,θ0−1,S10,S20)∈Hs. Then there exists a positive constant δ such that if ‖(ρ0−1,u0,θ0−1,S10,S20)‖s≤δ, there exists a global unique solution (ρ,u,θ,S1,S2) to the system (1.7), (2.11) satisfying
{(ρ−1,u,S1,S2)∈C([0,∞),Hs)∩C1([0,∞),Hs−1),(θ−1)∈C([0,∞),Hs)∩C1([0,∞,Hs−2). | (2.13) |
We remark that Kawashima's results also imply decay properties of the solutions, that is,
‖(ρ−1,u,θ−1,S1,S2)‖s−(s0+1)→0,ast→∞. |
Moreover, for n=3, if we further assume s≥s0+2 and ‖(ρ−1,u,θ−1,S1,S2)‖Lp≤δ where p∈[1,32], then the solutions have the following decay:
‖(ρ−1,u,θ−1,S1,S2)‖s−1≤C(1+t)−32(1p−12)‖(ρ0−1,u0,θ0−1,S10,S20)‖s−1,p, |
where the constant C is neither depending on t nor on the data.
The compatibility of the revised Maxwell law with the Newtonian law in terms of the limit τ1=τ2=:τ↓0 is described in the next theorem, where the following natural compatibility conditions on the initial data are assumed:
S10=μ(∇u0+(∇u0)T−2ndivu0In),S20=λdivu0. | (2.14) |
Denote by (ρτ,uτ,θτ,Sτ1,Sτ2) the solutions given by Theorem 2.4 with G1 satisfying G0⊂⊂G1⊂⊂G. Denoting
Tτ=sup{T>0,(ρτ−1,uτ,θτ−1,Sτ1,Sτ2)∈C([0,T],Hs),(ρτ,uτ,θτ,Sτ1,Sτ2)∈G1}, |
we have:
Theorem 2.6 ([23]). Let (ρ,u,θ) be a smooth solution to the classical compressible Navier-Stokes equations with (ρ(x,0),u(x,0),θ(x,0))=(ρ0,u0,θ0) satisfying
ρ∈C([0,T∗],Hs+3)∩C1([0,T∗],Hs+2),(u,θ)∈C([0,T∗],Hs+3)∩C1([0,T∗],Hs+1) |
with T∗>0 (finite). Then there are positive constants τ0 and C such that for τ≤τ0,
‖(ρτ,uτ,θτ)(t,⋅)−(ρ,u,θ)(t,⋅)‖s≤Cτ | (2.15) |
and
‖Sτ1(t,⋅)−μ(∇u+(∇u)T−2ndivuIn)(t,⋅)‖s+‖Sτ2(t,⋅)−λdivu(t,⋅)‖s≤Cτ12 | (2.16) |
for t∈[0,min{T∗,Tτ}), where C does not depend on τ.
Introducing the variables S01:=μ(∇u+∇uT−2ndivuIn),S02:=λdivu and defining
ρd:=ρτ−ρτ,ud:=uτ−uτ,θd:=θτ−θτ,Sd1:=Sτ1−S01τ,Sd2:=Sτ2−S02τ, | (2.17) |
the aim is to show that, for small τ and for t<min{T∗,Tτ},
‖(ρd,ud,θd)(t,⋅)‖s≤C,‖√τ(Sd1,Sd2)(t,⋅)‖s≤C, | (2.18) |
where C>0 denotes constants not depending on τ or t. This is achieved using the energy method combined with sophisticated estimates of the nonlinear terms.
For Model 3 in one space dimension with differential equations (1.8)–(1.10), where we consider two relaxations with nonlinearities in the relaxed equations reflecting the Galilean invariance, we have the initial conditions
(ρ(x,0),u(x,0),θ(x,0),q(x,0),S(x,0))=(ρ0,u0,θ0,q0,S0). | (2.19) |
We recall that the internal energy e and the pressure p are assumed to have the form (1.11) (resp., (1.12)) and satisfy the thermodynamic equation ρ2eρ=p−θpθ. Using this we may rewrite the differential equations as follows:
{ρt+(ρu)x=0,ρut+ρuux+pρρx+pθθx+pqqx+(pS−1)Sx=0,ρeθθt+(ρueθ−2qθ)θx+θpθux+qx=2q2κθ+S2μ,τ1(qt+uqx)+q+κθx=0,τ2(St+uSx)+S=μux. | (2.20) |
The system (2.20) is not symmetric. But one can show that there exists a δ such that if |(ρ−1,θ−1,q,S)|<δ, then the system (2.20) is strictly hyperbolic, since for the first-order system for V:=(ρ,u,θ,q,S)′, given by
Vt+A(V)∂xV+B(V)V=F(V), | (2.21) |
where
A(V)=(uρ000pρρupθρpqρpS−1ρ0θpθρeθu−2qρθeθ1000κτ1u00−μτ200u),B(V)=(0000000000000000001τ1000001τ2) | (2.22) |
and F(V):=(0,0,2q2κθ+S2μ,0,0)′, the eigenvalues of the matrix A(V) are then real and distinct. The following local existence theorem then follows, see [47], and it also implies that (2.20) is symmetrizable.
Theorem 2.7 ([27]). Let s≥2. Then there is δ>0 such that for (ρ0−1,u0,θ0−1,q0,S0)∈Ws,2(R) with ‖(ρ0−1,u0,θ0−1,q0,S0)‖s,2<δ, there exists a unique local solution (ρ,u,θ,q,S) to the system (1.8)–(1.10), (2.19) in some time interval [0,T] with
(ρ−1,u,θ−1,q,S)∈C0([0,T],Hs(R))∩C1([0,T],Hs−1(R)). | (2.23) |
The global well-posedness for small data is given by:
Theorem 2.8 ([27]). There exists ε>0 such that if
‖(ρ0−1,u0,θ0−1,q0,S0‖2H2<ε2, | (2.24) |
there exists a global solution (ρ,u,θ,q,S)(x,t)∈C1([0,+∞)×R) to the system (1.8)–(1.10), (2.19) satisfying
34≤supx,t(ρ(x,t),θ(x,t))≤54 |
and
supt∈[0,∞)‖(ρ−1,u,θ−1,q,S)‖2H2≤C‖(ρ0−1,u0,θ0−1,q0,S0‖2H2≤Cε2, | (2.25) |
where C is a constant which is independent of ε. Moreover, the solution converges uniformly in x∈R to the constant state (1,0,1,0,0) as t→∞. Namely,
‖(ρ−1,u,θ−1,q,S)‖L∞+‖(ρx,ux,θx,qx,Sx)‖L2→0ast→∞. |
For the proof, a series of a priori estimates for the local solution is derived, using the energy functional
E(t):=sup0≤s≤t‖(ρ−1,u,θ−1,q,S)(s,⋅)‖2H2+sup0≤s≤t‖(ρt,ut,θt,qt,St)‖2H1+∫t0‖(ρx,ρt,ux,ut,θx,θt,qx,qt,q,Sx,St,S)(s,⋅)‖2H1ds | (2.26) |
and the equality
[cvρ(θ−lnθ−1)+R(ρlnρ−ρ+1)+(1−12θ)τ1κθq2+12ρu2+τ22μS2]t+ [ρucv(θ−lnθ−1)+u(1−12θ)τ1κθq2+τ22μuS2+Rρulnρ−Rρu− qθ+12ρu3+pu+q−Su]x+q2κθ2+S2θμ=0, | (2.27) |
finally allowing to continue a local solution.
For a description of the singular limit, we assume τ1=τ2=:τ and the compatibility condition
S0=μ(u0)x,q0=−κ(θ0)x. |
Let (ρτ,uτ,θτ,qτ,Sτ) be solutions given by Theorem 2.7. Define
Tτ=sup{T>0;(ρτ−1,uτ,θτ−1,qτ,Sτ)∈C([0,T],H2),ρτ>0,θτ>0,∀(x,t)∈Rn×[0,T]}. |
Theorem 2.9 ([27]). Let (ρ,u,θ) be the smooth solution to the classical compressible Navier-Stokes equations with (ρ(x,0),u(x,0),θ(x,0))=(ρ0,u0,θ0) satisfying
inf(x,t)∈R×[0,T∗](ρ(x,t),θ(x,t))>0 |
and
(ρ−1)∈C([0,T∗],H5)∩C1([0,T∗],H4),(u,θ−1)∈C([0,T∗],H5)∩C1([0,T∗],H3), |
with finite T∗>0. Then, there exist constants τ0 and C such that for τ≤τ0,
‖(ρτ,uτ,θτ)(t,⋅)−(ρ,u,θ)(t,⋅)‖H2≤Cτ, | (2.28) |
and
‖(qτ+κθx,Sτ−μux)‖H2≤Cτ12, | (2.29) |
for all t∈(0,min(T∗,Tτ)), and the constant C is independent of τ.
The proof again looks at the differential equations for the differences ρd=ρτ−ρτ, ud=uτ−uτ, θd=θτ−θτ, qd=qτ−qτ, Sd=Sτ−Sτ, where q=−κθx and S=μux. For small τ and t<min{T∗,Tτ}, one proves
‖(ρd,ud,θd)(t,⋅)‖H2≤C,‖√τ(qd,Sd)(t,⋅)‖H2≤C, | (2.30) |
with C>0 not depending on τ. Here, on a technical level, the H5-regularity is needed.
For Model 4 in higher dimensions with differential equations (1.13) and initial conditions
(ρ(x,0),u(x,0),θ(x,0),q(x,0),S2(x,0))=(ρ0,u0,θ0,q0,S20), | (2.31) |
we distinguish the cases μ>0 and μ=0.
For μ>0_, the local existence theorem reads:
Theorem 2.10 ([33]). Suppose that the initial data (ρ0−1,u0,θ0−1,q0,S20)∈H3. Then there exists T=T(‖(ρ0,…,S20)‖H3)>0, such that the system (1.13), (2.31) has an unique classical solution (ρ,u,θ,q,S2) satisfying
(ρ−1,θ−1,q,S2)∈C([0,T],H3)∩C1([0,T],H2)u∈C([0,T],H3)∩C1([0,T],H1). |
The proof rewrites the system as a symmetric hyperbolic-parabolic one and uses the results of Kawashima, see [42] or [44].
For the global existence for small data let
En(t):=sup0≤τ≤t‖(ρ−1,u,θ−1,q,S2)(τ,⋅)‖2H3+∫t0(‖(∇ρ,∇θ)‖2H2+‖(q,S2)‖2H3+‖∇u‖2H3)dt. | (2.32) |
Then we have:
Theorem 2.11 ([33]). Let τ1>0,τ2=0,τ3>0, and μ>0. Suppose for the initial data
(ρ0−1,u0,θ0−1,q0,S20)∈H3. |
Then, there exists a small constant δ>0 such that if En(0)<δ, then the system (1.13), (2.31) has a unique solution (ρ,u,θ,q,S2) globally in time such that (ρ−1,u,θ−1,q,S2)∈C(0,+∞;H3), (∇ρ,∇θ)∈L2(0,+∞;H2), ∇u∈L2(0,+∞;H3), (q,S2)∈L2(0,+∞;H3).
For any t>0, we have
‖(ρ−1,u,θ−1,q,S2)‖2H3+∫t0(‖(∇ρ,∇θ)‖2H2+‖∇u‖2H3+‖(q,S2)‖2H3)dt≤CEn(0), | (2.33) |
where C is a constant being independent of t and of the initial data. Moreover, the solution decays in the sense
‖∇(ρ,u,θ,q,S2)‖L2→0 as t→∞. | (2.34) |
The long proof consists of energy estimates using the entropy relation
∂t(ρη)+div(ρuη)+div(qθ)=q2κθ2+S22θλ+S212μθ | (2.35) |
for the entropy η defined by
η:=Cvlnθ−Rlnρ+τ12κθ2ρq2, | (2.36) |
and the dissipative relation
∂t[Cvρ(θ−lnθ−1)+R(ρlnρ−ρ+1)+(1−12θ)τ1κθq2+12ρu2+τ32λS22]+ div[Cvρu(θ−lnθ−1)+u(1−12θ)τ1κθq2+τ32λuS22+Rρulnρ−Rρu− qθ+12ρu|u|2+pu+q−μu(∇u+∇uT−2ndivuIn)−S2u]+ q2κθ2+S22θλ+μ2θ|∇u+∇uT−2ndivuIn|2=0. | (2.37) |
Assuming again for simplicity τ1=τ3=:τ and letting (ρτ,uτ,θτ,qτ,Sτ2) denote the local solution defined on [0,Tτ), we have:
Theorem 2.12 ([33]). Let (ρ,u,θ) be the smooth solution to the classical compressible Navier-Stokes equations with (ρ(x,0),u(x,0),θ(x,0))=(ρ0,u0,θ0) satisfying
inf(x,t)∈R3×[0,T∗](ρ(x,t),θ(x,t))>0 |
and
(ρ−1)∈C([0,T∗],H6)∩C1([0,T∗],H5),(u,θ−1)∈C([0,T∗],H6)∩C1([0,T∗],H4), |
with finite T∗>0. Moreover, assume that the initial data satisfy
‖(ρτ0−ρ0,uτ0−u0,θτ0−θ0,√τ(qτ0+κ∇θ0),√τ(Sτ20−λdivu0))‖H3≤τ. |
Then, there exist constants τ0 and C>0 such that for τ≤τ0,
‖(ρτ,uτ,θτ)(⋅,t)−(ρ,u,θ)(⋅,t)‖H3≤Cτ, | (2.38) |
and
‖(qτ+κ∇θ,Sτ2−λ∇u)‖H3≤Cτ12, | (2.39) |
for all t∈(0,min(T∗,Tτ)), and the constant C is independent of τ.
The proof can be done in the spirit of corresponding considerations in [23], overcoming a higher complexity given here by energy estimates similar to those used in the proof of Theorem 2.11.
Peng and Zhao [45] studied the 1D version and obtained in particular a global existence result which is uniform with respect to τ as well as a global convergence result in a weak topology.
For the case μ=0_, we have a local existence theorem. In Section 4, a blow-up result will be presented. The differential equations (1.13) reduce to a purely hyperbolic one with zero-order damping terms,
{∂tρ+div(ρu)=0,ρ∂tu+ρu⋅∇u+∇p=∇S2,ρ∂te+ρu⋅∇e+pdivu+divq=S2divu,τ1(∂tq+u⋅∇q)+q+κ∇θ=0,τ3(∂tS2+u⋅∇S2)+S2=λdivu. | (2.40) |
The existence of solutions to (2.40) with initial conditions (2.31), even locally, is not immediately clear, since it is neither symmetric nor strictly hyperbolic. By carefully calculating the eigenvalues and eigenvectors of the corresponding matrix in the associated first-order system, one realizes that it is a constantly hyperbolic system, and thus has a local solution.
Assume that there exists δ>0, sufficiently small, such that
minx∈Rn(ρ0(x),θ0(x))>0,maxx∈Rn(|ρ0−1|,|θ0−1|,|q0(x)|,|S20(x)|)≤δ2. | (2.41) |
Then we have:
Theorem 2.13. ([33]) Let s>n2+1 and (ρ0,u0,θ0,q0,S20):Rn→R2n+3 be given with
ρ0−1,u0,θ0−1,q0,S0∈Hs. |
Then, there exists a unique local solution (ρ,u,θ,q,S2) to system (2.40), (2.31) in some time interval [0,T0) with
(ρ−1,u,θ−1,q,S2)∈C0([0,T0),Hs)∩C1([0,T0),Hs−1) |
and
min(x,t)∈Rn×[0,T0)(ρ(x,t),θ(x,t))>0, |
max(x,t)∈Rn×[0,T0)(|ρ(x,t)−1|,|θ(x,t)−1|,|q(x,t)|,|S2(x,t)|)≤δ. |
For the proof, one rewrites the system as a first-order system for V:=(ρ,u,θ,q,S2)T,
∂tV+3∑j=1Aj(V)∂xjV+B(V)V=F(V), | (2.42) |
where
3∑j=1Ajξj=(u⋅ξρξT000pρρξ(u⋅ξ)InpθρξpqρξTpS2−1ρξ0θpθρeθξT(u−2qρθeθ)ξξT000κτ1ξ(u⋅ξ)In00−λτ3ξT00u⋅ξ),B(V)=diag{0,0,0,1τ1,1τ3},F(V)=(0,0,2κθq2+1λS22,0,0)T. |
Since the (2n+3)×(2n+3)-matrix n∑j=1Ajξj is not symmetric, the system (2.42) is neither symmetric-hyperbolic nor strictly hyperbolic, and a symmetrizer is not obvious. So, the local existence does not follow immediately by the classical theory of symmetric-hyperbolic or strictly hyperbolic systems. Carefully analyzing the dimensions of the eigenspaces of the eigenvalues of the matrix, here using the smallness assumption (2.41), it can be shown that the system is constantly hyperbolic. Referring to [46, Thm. 2.3 and Thm. 10.2], we conclude the local well-posedness.
The last Model 5, a modification of Model 3, considers, in one dimension, the differential equations (1.16)–(1.18) together with the constitutive equations (1.19), (1.20), and the initial conditions
(ρ(x,0),u(x,0),θ(x,0),q(x,0),S(x,0))=(ρ0,u0,θ0,q0,S0). | (2.43) |
It is assumed that, for θ>0,
a(θ)>0,a′(θ)≥0,12(Z(θ)θ)′≥0 | (2.44) |
holds. The assumption a′(θ)≥0 implies eθ≥Cv>0, which make the system (1.16)–(1.18) uniformly hyperbolic without a smallness condition. The third inequality in (2.44) will give the L2 estimates of q, which will be used in the blow-up result in Section 5. Note that by choosing Z(θ)=τ1(θ)κ(θ)=kθα with k as any constant and 1≤α<2, the assumption (2.44) holds.
Now, we transform the equations (1.16)–(1.18) into a first-order symmetric hyperbolic system. First, we rewrite the equation (1.16)3 for θ as
ρeθθt+(ρueθ−2a(θ)Z(θ)q)θx+Rρθux+qx=2a(θ)τ1(θ)q2+1μS2. | (2.45) |
Then, we have
A0(U)Ut+A1(U)Ux+B(U)U=F(U), | (2.46) |
where U=(ρ,u,θ,q,S) and
A0(U)=diag{Rθρ,ρ,ρeθθ,τ1(θ)ρκ(θ),τ2ρμ},A1(U)=(RθρuRθ000RθρuRρ0−10Rρ(ρueθθ−2a(θ)θZ(θ)q)1θ0001θτ1(θ)κ(θ)ρu00−100τ2μρu),B(U)=diag{0,0,0,1κθ,1μ},F(U)=diag{0,0,−2a(θ)τ1(θ)θq2−S2μθ,0,0}. |
Therefore, the local existence follows immediately, see [42,43,47]:
Theorem 2.14 ([35]). Let s≥2. Suppose that
(ρ0−1,u0,θ0−1,q0,S0)∈Hs(R) |
with minx(ρ0(x),θ0(x))>0, then there exists a unique local solution (ρ,u,θ,q,S) to the system (1.16)–(1.18), (2.43) in some time interval [0,T] with
(ρ−1,u,θ−1,q,S)∈C0([0,T],Hs(R))∩C1([0,T],Hs−1(R)), | (2.47) |
minx(ρ(t,x),θ(t,x))>0,∀t>0. | (2.48) |
In this section, we present a blow-up result for large data in the one-dimensional case of Model 3. We recall the differential equations (1.8)–(1.10) and the constitutive equations (1.11), (1.12),
{ρt+(ρu)x=0,ρut+ρuux+px=Sx,ρet+ρuex+pux+qx=Sux, | (3.1) |
with
τ1(qt+uqx)+q+κθx=0, | (3.2) |
and
τ2(St+uSx)+S=μux, | (3.3) |
e=Cvθ+τ1κθρq2+τ22μρS2, | (3.4) |
p=Rρθ−τ12κθq2−τ22μS2. | (3.5) |
The initial conditions are given by
(ρ(x,0),u(x,0),θ(x,0),S(x,0),q(x,0))=(ρ0,u0,θ0,S0,q0). | (3.6) |
The local well-posedness and the global existence for small data were given in Theorem 2.7 and Theorem 2.8, respectively. When τ1=τ2=0, the system is reduced to the classical compressible Navier-Stokes equations for which smooth solutions exist globally for arbitrary initial data away from a vacuum, see [48]. On the other hand, when the relaxation parameters go to zero, smooth solutions of the system converge to that of the classical system, see Theorem 1.17. This indicates that the relaxed system exhibits a similar qualitative behavior as the classical system. However, and surprisingly, we show that there are in general no C1-solutions to the system (3.1)–(3.3) for some large initial data. That is, we have another nonlinear system where the relaxation process turns a (globally) well-posed system into a not (globally) well-posed one, only visible in the nonlinear system, since the linearized systems behave similarly, see [49]. This sheds light on the difficulties in proving some global existence results in fluid dynamics, and in finding the "correct" model.
We choose δ>0 small enough such that pρ,pθ,eθ are positive and bounded away from zero and |pS|,|pq| are sufficiently small as functions of (ρ,θ,q,S) on
Ω:=(1−δ,1+δ)×(1−δ,1+δ)×(−δ,δ)×(−δ,δ). | (3.7) |
The method to prove the blow-up result is mainly motivated by Sideris' paper [41] where he showed that any C1 solutions of compressible Euler equations must blow up in finite time. As was shown in [19], the system (3.1)–(3.3) is a strictly hyperbolic system which implies the property of finite propagation speed, which in turn allows one to define some averaged quantities as in [41] and finally show a blow-up of solutions in finite time by establishing a Riccati-type inequality.
The finite propagation speed is expressed in:
Lemma 3.1. ([49]) Let (ρ,u,θ,q,S) be a local solution to (3.1)–(3.3), (3.6) on [0,T0). Let M>0. Assume that the initial data (ρ0−1,u0,θ0−1,q0,S0) are compactly supported in (−M,M) and (ρ0,θ0,q0,S0)∈Ω. Then, there exists a constant σ such that
(ρ(⋅,t),u(⋅,t),θ(⋅,t),q(⋅,t),S(⋅,t)=(1,0,1,0,0):=(ˉρ,ˉu,ˉθ,ˉq,ˉS) |
on D(t)={x∈R||x|≥M+σt},0≤t<T0.
The averaged quantities used are
F(t):=∫Rxρ(x,t)u(x,t)dx, | (3.8) |
G(t):=∫R(E(x,t)−ˉE)dx, | (3.9) |
where
E(x,t):=ρ(e+12u2) |
is the total energy and
ˉE:=ˉρ(ˉe+12ˉu2)=Cv. |
Now the blow-up result is given by:
Theorem 3.2. ([49]) Assuming
G(0)>0, | (3.10) |
there exists u0 satisfying
F(0)>max{32σmaxρ03−γ,4√maxρ0√3−γ}M2,1<γ:=1+RCv<3 | (3.11) |
such that the length T0 of the maximal interval of existence of a smooth solution (ρ,u,θ,q,S) to (3.1)–(3.3), 3.6 is finite, provided the compact support of the initial data is sufficiently large.
The assumption 1<γ<3 holds for the elementary kinetic theory of gases, cf. [41]. Note that it is assumed that the local solution satisfies (ρ,θ,q,S)(t)∈Ω. This a priori assumption does not affect u, which blows up, but is a restriction; the solutions might reach the boundary. In Section 5, we will consider Model 5, a modification of Model 3, and show a blow-up result excluding this possibility.
Sketch of the proof of Theorem 3.2: Using the constitutive equations and the constancy of G, we get
F′(t)≥3−γ2∫Rρu2dx−∫Rτ1(2γ−1)2κθq2dx−∫R(τ2(2γ−1)2μ+12)S2dx−(M+σt). | (3.12) |
On the other hand
F2(t)=(∫Rxρ(x,t)u(x,t)dx)2≤∫Btx2ρdx⋅∫Btρu2dx≤(M+˜σt)2∫Btρdx⋅∫Btρu2dx=(M+˜σt)2∫Btρ0dx⋅∫Btρu2dx≤2maxρ0(M+˜σt)3∫Rρu2dx, |
where Bt={x∈R||x|≤M+˜σt} = (−(M+˜σt),M+˜σt) and ˜σ≥σ can be chosen arbitrary. For simplicity, we still denote ˜σ by σ in the following calculations. Therefore, we have
F′(t)≥3−γ4maxρ0(M+σt)3F2−∫Rτ1(2γ−1)2κθq2dx−∫Rτ2(2γ−1)+μ2μS2dx− (M+σt). | (3.13) |
Let
c2:=σM,c3:=3−γ4maxρ0M3. |
Assume, for the moment a priori,
F(t)≥c1>0 | (3.14) |
and
M+σt=M(1+c2t)≤c32(1+c2t)3F2, | (3.15) |
where c1 is to be determined later. Then
F′(t)F2≥c32(1+c2t)3−τ1(2γ−1)c21κˉθ∫Rq2dx−τ2(2γ−1)+μc212μ∫RS2dx. | (3.16) |
Using the identity (2.27) and defining
H0:=∫R(Cvρ0(θ0−lnθ0−1)+R(ρ0lnρ0−ρ0+1)+(1−12θ0)τ1κθq20+τ22μS20)dx, |
we obtain
τ1(2γ−1)c21κˉθ∫t0∫Rq2dxdt+τ2(2γ−1)+μc212μ∫t0∫RS2dxdt≤c4+c5‖u0‖2L2, | (3.17) |
where
c4:=1c21[ˉθ(4τ1(2γ−1)+τ2(2γ−1)+μ)H0] |
and
c5:=1c21[ˉθ(4τ1(2γ−1)+τ2(2γ−1)+μ)maxρ02]. |
Integrating the inequality (3.16), we get
1F0−1F≥−c34c2(1+c2t)2+c34c2−c4−c5‖u0‖2L2. | (3.18) |
Now we assume additionally and a priori
F0>8c2c3 | (3.19) |
and
c4+c5‖u0‖2L2≤c38c2. | (3.20) |
Then, we get
1F0≥1F0−1F≥−c34c2(1+c2t)2+c38c2, | (3.21) |
which means that T0 cannot be arbitrarily large without contradicting (3.19). It remains to show that the a priori assumptions (3.14), (3.15), (3.19), and (3.20) can be justified.
(3.14) is easy to show with c1:=2c2c3. For (3.15) to hold, we only need to show the following inequality:
M(1+c2t)≤c34(1+c2t)3F2. | (3.22) |
For t=0, it is sufficient to guarantee
σ2≥3−γ16maxρ0, | (3.23) |
which is satisfied naturally since σ can be chosen arbitrarily large. Thus, the proof will be finished if we can show the existence of u0 such that (3.19) and (3.20) hold, and the assumption (3.10) is satisfied. As in [19], we choose u0∈H2(R)∩C1(R) as follows:
u0(x):={0,x∈(−∞,−M],L2cos(π(x+M))−L2,x∈(−M,−M+1],−L,x∈(−M+1,−1],Lcos(π2(x−1)),x∈(−1,1],L,x∈(1,M−1],L2cos(π(x−M+1))+L2,x∈(M−1,M],0,x∈(M,∞), | (3.24) |
where L is a positive constant to be determined later. We assume M≥4. Assumption (3.10) can easily be satisfied since it is equivalent to requiring
∫R(ρ0e0−ˉρˉe+12u20)dx>0, |
which is satisfied by choosing ρ0θ0>ˉρˉθ=1. Since
F0=∫Rxρ0(x)u0(x)dx≥L2minρ0M2, |
we can choose L large enough, independent of M, such that
L2minρ0>max{32σmaxρ03−γ,4√maxρ0√3−γ} |
implying (3.19). On the other hand, since ‖u0‖2L2≤2L2M, we can choose M sufficiently large such that
ˉθ(8γτ1+2γτ2+μ)(H0+maxρ0ML2)≤2σmaxρ0(3−γ)M2 |
holds, implying (3.20), and the proof is finished.
A blow-up result is presented for Model 4 in the case μ=0, in dimensions n=2,3. We recall the differential equations (2.40) and the initial conditions (2.31):
{∂tρ+div(ρu)=0,ρ∂tu+ρu⋅∇u+∇p=∇S2,ρ∂te+ρu⋅∇e+pdivu+divq=S2divu,τ1(∂tq+u⋅∇q)+q+κ∇θ=0,τ3(∂tS2+u⋅∇S2)+S2=λdivu, | (4.1) |
(ρ(x,0),u(x,0),θ(x,0),q(x,0),S2(x,0))=(ρ0,u0,θ0,q0,S20). | (4.2) |
Additionally, we assume the specified constitutive equations (1.14), (1.15),
e=Cvθ+τ1κρθq2+τ32λρS22, | (4.3) |
p=Rρθ−τ12κθq2−τ32λS22. | (4.4) |
A local solution was given in Theorem 2.13. For the blow-up result, we need to assume there exists δ>0, sufficiently small, such that
maxx∈Rn(|ρ0−1|,|θ0−1|,|q0(x)|,|S20(x)|)≤δ2 | (4.5) |
and that this implies on the interval of local existence
maxx∈Rn(|ρ0−1|,|θ0−1|,|q0(x)|,|S20(x)|)≤δ. | (4.6) |
We remark that this assumption does not affect u which is shown to blow-up in finite time. The finite propagation speed of the hyperbolic system is expressed in:
Lemma 4.1. ([33]) Let (ρ,u,θ,q,S2) be the local solution to (4.1), (4.2) on [0,T0). We further assume that the initial data (ρ0−1,u0,θ0−1,q0,S20) are compactly supported in a ball B0(M) with radius M>0. Then, there exists a constant σ such that
(ρ(⋅,t),u(⋅,t),θ(⋅,t),q(⋅,t),S2(⋅,t))=(1,0,1,0,0)=:(ˉρ,ˉu,ˉθ,ˉq,ˉS2) | (4.7) |
on D(t):={x∈Rn||x|≥M+σt},0≤t<T0.
The following averaged quantities are used, cf. Section 3:
F(t):=∫Rnx⋅ρ(x,t)u(x,t)dx, | (4.8) |
G(t):=∫Rn(E(x,t)−ˉE)dx, | (4.9) |
where E(x,t):=ρ(e+12u2) is the total energy and ˉE:=ˉρ(ˉe+12ˉu2)=Cv. Then we have:
Theorem 4.2. Let (ρ,u,θ,q,S2) be the local solution to (4.1), (4.2) on [0,T0). Assume that the initial data (ρ0−1,u0,θ0−1,q0,S20) are compactly supported in a ball B0(M) with radius M>0. Moreover, we assume that
G(0)>0, | (4.10) |
1<γ:=1+RCv<53. | (4.11) |
Then, there exists u0 satisfying
F(0)>max{128σmaxρ03(5−3γ),8√πmaxρ0√3(5−3γ)}M4, | (4.12) |
such that the length T0 of the maximal interval of existence of a smooth solution (ρ,u,θ,q,S2) is finite, provided the compact support of the initial data is sufficiently large.
This blow-up result relies on assumption (4.6) assuring the remaining of the solutions in the hyperbolic region, cf. the remarks in Section 3. A modification of the system, as done for Model 3 in Model 5, might remove this assumption, see Sections 3 and 5. The proof is similar to that of Theorem 3.2 in Section 3 and is presented for the case n=3. The case n=2 is proved by easy modifications.
Sketch of the proof of Theorem 4.2: Using the constancy of G and the constitutive equations (4.3), (4.4), we conclude
F′(t)≥5−3γ2∫R3ρu2dx−3∫R3τ1γκθq2dx−3∫R3(τ3γλ+12)S22dx−2π(M+σt)3. | (4.13) |
Similar to the one-dimensional case discussed in Section 3, we obtain
F′(t)≥3(5−3γ)8πmaxρ0(M+σt)5F2−3∫R3(τ1γκθq2+2τ3γ+λ2λS22)dx−2π(M+σt)3. | (4.14) |
Let c2:=σM,c3:=3(5−3γ)8πmaxρ0M5. We assume a priori for the moment
F(t)≥c1>0 | (4.15) |
and
2π(M+σt)3=2πM3(1+c2t)3≤c32(1+c2t)5F2, | (4.16) |
where c1 is to be determined later. Then
F′(t)F2(t)≥c32(1+c2t)5−6τ1γc21κˉθ∫R3q2dx−6τ3γ+3λc212λ∫R3S22dx. | (4.17) |
Using the the dissipative entropy equation (2.37), with μ=0, and
W0:=∫R3(Cvρ0(θ0−lnθ0−1)+R(ρ0lnρ0−ρ0+1) +(1−12θ0)τ1κθq20+τ22λS220)dx, |
we obtain
6τ1γc21κˉθ∫t0∫R3q2dxdt+6τ3γ+3λc212λ∫t0∫R3S22dxdt≤c4+c5‖u0‖2L2, | (4.18) |
where
c4=3c21[ˉθ(8τ1γ+2τ3γ+λ)W0],c5=3c21[ˉθ(8τ1γ+2τ3γ+λ)maxρ02]. |
Integrating (4.17), we have
1F0−1F(t)≥−c38c2(1+c2t)4+c38c2−c4−c5‖u0‖2L2. | (4.19) |
Now, we additionally assume a priori
F0>16c2c3, | (4.20) |
c4+c5‖u0‖2L2≤c316c2. | (4.21) |
Then we get
1F0≥1F0−1F(t)≥−c38c2(1+c2t)4+c316c2 | (4.22) |
which implies that the maximal time of existence T cannot be arbitrarily large without contradicting (4.20). It remains to show that the a priori assumptions (4.15), (4.16), (4.20), and (4.21) can be justified.
(4.15) is easy to show with c1:=4c2c3. For (4.16) to hold, it suffices to show
2πM3(1+c2t)3≤c34(1+c2t)5F(t)2. | (4.23) |
For t=0, it is sufficient to guarantee
σ2≥3(5−3γ)64maxρ0, | (4.24) |
which is satisfied naturally since σ can be chosen arbitrarily large. Thus, the proof will be finished if we can show the existence of u0 such that (4.20) and (4.21) hold and the assumption (4.10) is satisfied. Let
˜v(r)={Lcos(π2(r−1)),r∈[0,1],L,r∈(1,M−1],L2cos(π(r−M+1))+L2,r∈(M−1,M],0,r∈(M,+∞), | (4.25) |
where L is a positive constant to be determined later. ˜v is not in H3(R+), but we can think of ˜v being smoothed around the singular points r=1,M−1,M and put to zero around r=0, yielding a function v, with ‖v‖L2≤2‖˜v‖L2. We choose
u0(x):=v(|x|)x|x|. |
Assumption (4.10) can easily be satisfied since it is equivalent to requiring
∫R3(ρ0e0−ˉρˉe+12u20)dx>0, |
which is satisfied by choosing ρ0θ0>ˉρˉθ=1. Let M≥5. Since
F0=∫R3x⋅ρ0(x)u0(x)dx≥πminρ032LM4, |
we can choose L sufficiently large, independent of M, such that
πminρ032L≥max{√64πmaxρ03(5−3γ),128σπmaxρ03(5−3γ)}, |
implying (4.20). On the other hand, since ‖u0‖2L2≤4L24π3M3, we can choose M sufficiently large such that
ˉθ(8τ1γ+2τ2γ+μ)(W0+2πmaxρ0L23M3)≤16πσmaxρ09(5−3γ)M4 |
holds, implying (4.21), and the proof is finished.
Here we present a second blow-up result in one dimension, for Model 5 being a modification of Model 3, avoiding the possibility of reaching the hyperbolic boundary, cf. Section 3. We recall the differential equations and the initial conditions,
{ρt+(ρu)x=0,ρut+ρuux+px=Sx,Et+(uE+pu+q−Su)x=0, | (5.1) |
where E represents the total energy,
τ1(θ)(ρqt+ρu⋅qx)+q+κ(θ)θx=0, | (5.2) |
and
τ2(ρSt+ρu⋅Sx)+S=μux, | (5.3) |
(ρ(x,0),u(x,0),θ(x,0),q(x,0),S(x,0))=(ρ0,u0,θ0,q0,S0), | (5.4) |
as well as the constitutive equations
E=12ρu2+τ22μρS2+ρe(θ,q), | (5.5) |
and the specific internal energy e and the pressure p are given by
e(θ)=Cvθ+a(θ)q2,p(ρ,θ)=Rρθ, | (5.6) |
where
a(θ)=Z(θ)θ−12Z′(θ)withZ(θ)=τ1(θ)κ(θ). |
The local existence is given in Theorem 2.14. Neglecting ρ in the constitutive relations (1.3)–(1.5) and assuming τ1,κ to be constants, in Section 3 a blow-up result was established under the assumption that (ρ−1,θ−1,q,S)∈Ω with Ω=((−δ,δ))4 being a "small" domain requiring δ to be sufficiently small to assure that the arising system is — though non-symmetric — strictly hyperbolic, which, in turn, assures the local solvability. This smallness of |(ρ−1,θ−1,q,S)| — notice: not including u — has been established globally only for small data. Therefore, the solutions in Section 3 might "blow up" in the sense that one may reach the boundary of Ω. In the present paper, the system is a symmetric hyperbolic one, not requiring any smallness condition of this kind.
The most interesting aspect, as in Section 3, might be that the blow-up result contrasts the situation without relaxation. i.e., for the classical compressible Navier-Stokes system corresponding to τ1=τ2=0, where large global solutions exist, see Kazhikhov [48]. This really nonlinear effect — loosing the global existence for large data —, not anticipated from the linearized version, shows the possible impact a relaxation might have. For several linear systems of various type an effect is visible in loosing exponential stability in bounded domains or becoming of regularity loss type in the Cauchy problem, see the discussion in our paper [49].
The method we use to prove the blow-up result is mainly motivated by Sideris' paper [41] where he showed that any C1-solutions of compressible Euler equations must blow up in finite time. A blow-up result for a similar system has also been proved recently by Freistühler [50] applying the general result for hyperbolic systems with sources in one space dimension by Bärlin [51]. A solution remains bounded, but the solution does not remain in C1, provided the data are small enough. In contrast to [50,51], our blow-up requires large initial velocities; moreover, here the largeness is described explicitly. For initial data being small in higher-order Sobolev spaces (H2), there exist global solutions. The method used here, and before in Sections 3 and 4, also extends to higher dimensions, as seen in Section 4.
Since the system is symmetric hyperbolic, the local solution possesses the finite propagation speed property:
Lemma 5.1. Let (ρ,u,θ,q,S) be the local solution according to Theorem 2.14 on [0,T0). Let M>0. We assume that the initial data (ρ0−1,u0,θ0−1,q0,S0) are compactly supported in (−M,M). Then, there exists a constant σ such that
(ρ(⋅,t),u(⋅,t),θ(⋅,t),q(⋅,t),S(⋅,t)=(1,0,1,0,0):=(ˉρ,ˉu,ˉθ,ˉq,ˉS) |
on D(t)={x∈R||x|≥M+σt},0≤t<T0.
We define again some averaged quantities,
F(t):=∫ρu⋅xdx−τ2∫ρSdx, | (5.7) |
G(t):=∫R(E(x,t)−ˉE)dx, | (5.8) |
where
E=12ρu2+τ22μρS2+ρe(θ,q) |
is the total energy and
ˉE:=ˉρ(ˉe+12ˉu2)=Cv. |
The functional F with the second term involving S is different from those used in [41] and [49] (resp., Section 3). This second term is new and technically motivated. The blow-up result is now given by:
Theorem 5.2. We assume
G(0)>0. | (5.9) |
Then, there exists (ρ0,u0,θ0,q0,S0) satisfying
F(0)>32σmaxρ03−γM2 | (5.10) |
and
4((3−γ)μτ2M2+γ−1)(H0+maxρ02‖u0‖2L2)≤128σ2maxρ0M3−γ, | (5.11) |
where
H0:=∫Cvρ0(θ0−lnθ0−1)+R(ρ0lnρ0−ρ0+1)+ρ0(a(θ0)+12(Z(θ0)θ0)′)q20+τ22μS20dx, | (5.12) |
such that the length T0 of the maximal interval of existence of a smooth solution (ρ,u,θ,q,S) to system (1.16)–(1.18), (2.43) is finite, provided the compact support of the initial data is sufficiently large and γ:=1+RCv is sufficiently close to 1.
Sketch of the proof: It is in the line of the proofs of the blow-up theorems in Sections 3 and 4, but with a slightly higher complexity due to the necessarily modified quantity F, but also with an improved strategy.
The entropy η, defined by
η:=Cvlnθ−Rlnρ−(Z(θ)2θ)′q2, | (5.13) |
satisfies
(ρη)t+(ρuη+qθ)x=q2κ(θ)θ2+S2μθ. | (5.14) |
Using this and the constancy of G, we can derive
F′(t)≥3−γ2∫ρu2dx−(γ−1)(H0+maxρ02‖u0‖2L2). |
On the other hand, F satisfies
∫ρu2dx≥F(t)24maxρ0(M+σt)3−2μτ2(H0+maxρ02‖u0‖2L2)(M+σt)2. |
The last two estimates imply
F′(t)≥3−γ8maxρ0(M+σt)3F2(t)−((3−γ)μτ2(M+σt)2+γ−1)(H0+maxρ02‖u0‖2L2)≡c3(1+c2t)3F(t)2−K(t) | (5.15) |
where c2:=σM,c3:=3−γ8maxρ0M3. With this Riccati-type inequality, we can show the blow-up result. Indeed, assuming a priori that
2K(t)≤c3(1+c2t)3F2(t), | (5.16) |
we have
F′(t)≥c32(1+c2t)3F2(t), |
which gives
1F(0)≥1F(0)−1F(t)≥c34c2−c34c2(1+c2t)2. | (5.17) |
Hence, the maximal existence time T0 cannot be infinite provided
F(0)>4c2c3=32σmaxρ0M23−γ, | (5.18) |
which is equivalent to assumption (5.10). Using (5.18), we get
1F(t)≤1F(0)−c34c2+c34c2(1+c2t)2≤c34c2(1+c2t)2, | (5.19) |
which implies
F(t)≥4c2(1+c2t)2c3. | (5.20) |
To show that the a priori estimate (5.16) holds, we use the bootstrap method expressed in the following simple lemma.
Lemma 5.3. Let f∈C0([0,∞),[0,∞)) and 0<a<b such that the following holds for any 0≤α<β<∞:
f(0)<aand(∀t∈[α,β]:f(t)≤b⟹∀t∈[α,β]:f(t)≤a.). |
Then we have
∀t≥0:f(t)≤a. |
We will apply this lemma in the time domain of existence to f,a,b with
f(t):=K(t)(1+c2t)3F2(t)c3,a:=14,b:=12. |
That is, we need to show that
4K(t)≤c3(1+c2t)3F2(t). | (5.21) |
Next, to get (5.21), using (5.20), one only needs to show
4K(t)(1+c2t)3c3≤16c22c23(1+c2t)4 | (5.22) |
for which it is sufficient to show
4((3−γ)μτ2M2+γ−1)(H0+maxρ02‖u0‖2L2)≤16c22c3, | (5.23) |
since K is a decreasing function. The last inequality is equivalent to assumption (5.11). This proves (5.16).
Finally, we need to find some u0 such that the assumptions (5.10) and (5.11) hold. We choose, similarly to Sections 3 and 4, u0∈H2(R)∩C1(R) as follows:
u0(x):={0,x∈(−∞,−M],L2cos(π(x+M))−L2,x∈(−M,−M+1],−L,x∈(−M+1,−1],Lcos(π2(x−1)),x∈(−1,1],L,x∈(1,M−1],L2cos(π(x−M+1))+L2,x∈(M−1,M],0,x∈(M,∞), | (5.24) |
where L is a positive constant to be determined later. We assume M≥4. Assumption (5.9) can easily be satisfied since it is equivalent to requiring
∫R(ρ0e0−ˉρˉe+12u20)dx>0, |
which is satisfied by choosing ρ0θ0>ˉρˉθ=1. Since
∫R(xρ0(x)u0(x))dx≥L2minρ0M2 |
and
|τ2∫ρ0S0dx|≤∫M−Mρ0dx+τ2∫ρ0S20dx≤maxρ0(1+μH20)M2, |
we choose L large enough, and independent of M, such that
L4minρ0>max{maxρ0(1+μH20),32σmaxρ03−γ}. |
Therefore, (5.10) holds. Now, after having chosen σ large enough, fix L. Then we choose M sufficiently large and γ−1 sufficiently small such that (5.11) holds. This finishes the proof.
The author declares he has not used Artificial Intelligence (AI) tools in the creation of this article.
The author acknowledges with great gratitude the inspiring mathematical environment and hospitality experienced during various stays with Professor Thomas C. Sideris at the University of California at Santa Barbara.
The successful co-operation with Professor Yuxi Hu leading to the results presented in this survey is also gratefully acknowledged.
The author declares no conflict of interest in this paper.
[1] | Ader R, Felten DL, Cohen N (2001) Psychoneuroimmunology New York: Academic Press. |
[2] |
Seifert P, Spitznas M (2001) Tumours may be innervated. Virchows Arch 438: 228-231. doi: 10.1007/s004280000306
![]() |
[3] |
Seifert P, Benedic M, Effert P (2002) Nerve fibers in tumors of the human urinary bladder. Virchows Arch 440: 291-297. doi: 10.1007/s004280100496
![]() |
[4] |
Lu SH, Zhou Y, Que HP, et al. (2003) Peptidergic innervation of human esophageal and cardiac carcinoma. World J Gastroenterol 9: 399-403. doi: 10.3748/wjg.v9.i3.399
![]() |
[5] | Liang YJ, Zhou P, Wongba W, et al. (2010) Pulmonary innervation, inflammation and carcinogenesis. Sheng Li Xue Bao 62: 191-195. |
[6] |
Priyanka HP, ThyagaRajan S (2013) Selective modulation of lymphoproliferation and cytokine production via intracellular signaling targets by α1- and α2-adrenoceptors and estrogen in splenocytes. Int Immunopharmacol 17: 774-784. doi: 10.1016/j.intimp.2013.08.020
![]() |
[7] | Meites J, Quadri SK (1987) Neuroendocrine theories of aging. The Encyclopedia of Aging New York: Springer, 474-478. |
[8] |
ThyagaRajan S, MohanKumar PS, Quadri SK (1995) Cyclic changes in the release of norepinephrine and dopamine in the medial basal hypothalamus: effects of aging. Brain Res 689: 122-128. doi: 10.1016/0006-8993(95)00551-Z
![]() |
[9] | ThyagaRajan S, Priyanka HP (2012) Bidirectional communication between the neuroendocrine system and the immune system: relevance to health and diseases. Ann Neurosci 19: 40-46. |
[10] |
Mravec B, Gidron Y, Hulin I (2008) Neurobiology of cancer: interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain. Semin Cancer Biol 18: 150-163. doi: 10.1016/j.semcancer.2007.12.002
![]() |
[11] |
Mukhtar RA, Nseyo O, Campbell MJ, et al. (2011) Tumor-associated mac-rophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11: 91-100. doi: 10.1586/erm.10.97
![]() |
[12] |
Müller A, Homey B, Soto H, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56. doi: 10.1038/35065016
![]() |
[13] |
Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21: 309-322. doi: 10.1016/j.ccr.2012.02.022
![]() |
[14] |
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi: 10.1016/j.cell.2011.02.013
![]() |
[15] |
Cole SW, Nagaraja AS, Lutgendorf SK, et al. (2015) Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer 15: 563-572. doi: 10.1038/nrc3978
![]() |
[16] |
Segerstrom SC, Miller GE (2004) Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130: 601-630. doi: 10.1037/0033-2909.130.4.601
![]() |
[17] |
Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51: 27-41. doi: 10.1016/j.immuni.2019.06.025
![]() |
[18] |
Yang H, Xia L, Chen J, et al. (2019) Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med 25: 1428-1441. doi: 10.1038/s41591-019-0566-4
![]() |
[19] |
Curtin NM, Boyle NT, Mills KH, et al. (2009) Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav Immun 23: 535-547. doi: 10.1016/j.bbi.2009.02.003
![]() |
[20] |
Key TJ (1995) Hormones and cancer in humans. Mutat Res 333: 59-67. doi: 10.1016/0027-5107(95)00132-8
![]() |
[21] |
Mravec B, Tibensky M, Horvathova L (2020) Stress and cancer. Part I: Mechanisms mediating the effect of stressors on cancer. J Neuroimmunol 346: 577311. doi: 10.1016/j.jneuroim.2020.577311
![]() |
[22] |
Yin W, Gore AC (2006) Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction 131: 403-414. doi: 10.1530/rep.1.00617
![]() |
[23] | Reed BG, Carr BR (2000) The Normal Menstrual Cycle and the Control of Ovulation. Endotext South Dartmouth (MA): MDText.com, Inc. |
[24] |
Del Río JP, Alliende MI, Molina N, et al. (2018) Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance. Front Public Health 6: 141. doi: 10.3389/fpubh.2018.00141
![]() |
[25] |
Djahanbakhch O, Ezzati M, Zosmer A (2007) Reproductive ageing in women. J Pathol 211: 219-231. doi: 10.1002/path.2108
![]() |
[26] | Braunwald E, Isselbacher KJ, Petersdorf RG, et al. (1987) Harrison's Principles of Internal Medicine New York: McGraw-Hill, 1818-1837. |
[27] |
Priyanka HP, Nair RS (2020) Neuroimmunomodulation by estrogen in health and disease. AIMS Neurosci 7: 401-417. doi: 10.3934/Neuroscience.2020025
![]() |
[28] |
Sherman BM, West JH, Korenman SG (1976) The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42: 629-636. doi: 10.1210/jcem-42-4-629
![]() |
[29] |
Hall JE, Gill S (2001) Neuroendocrine aspects of aging of aging in women. Endocrinol Metab Clin North Am 30: 631-646. doi: 10.1016/S0889-8529(05)70205-X
![]() |
[30] |
Lang TJ (2004) Estrogen as an immunomodulator. Clin Immunol 113: 224-230. doi: 10.1016/j.clim.2004.05.011
![]() |
[31] |
Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3: 97-104. doi: 10.2174/1568010043483944
![]() |
[32] |
Wise PM, Scarbrough K, Lloyd J, et al. (1994) Neuroendocrine concomitants of reproductive aging. Exp Gerontol 29: 275-283. doi: 10.1016/0531-5565(94)90007-8
![]() |
[33] |
Chakrabarti M, Haque A, Banik NL, et al. (2014) Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull 109: 22. doi: 10.1016/j.brainresbull.2014.09.004
![]() |
[34] |
ThyagaRajan S, Madden KS, Teruya B, et al. (2011) Age-associated alterations in sympathetic noradrenergic innervation of primary and secondary lymphoid organs in female Fischer 344 rats. J Neuroimmunol 233: 54-64. doi: 10.1016/j.jneuroim.2010.11.012
![]() |
[35] |
Teilmann SC, Clement CA, Thorup J, et al. (2006) Expression and localization of the progesterone receptor in mouse and human reproductive organs. J Endocrinol 191: 525-535. doi: 10.1677/joe.1.06565
![]() |
[36] |
Butts CL, Shukair SA, Duncan KM, et al. (2007) Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol 19: 287-296. doi: 10.1093/intimm/dxl145
![]() |
[37] |
Jones LA, Kreem S, Shweash M, et al. (2010) Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone. J Immunol 185: 4525-4534. doi: 10.4049/jimmunol.0901155
![]() |
[38] |
Menzies FM, Henriquez FL, Alexander J, et al. (2011) Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology 134: 281-291. doi: 10.1111/j.1365-2567.2011.03488.x
![]() |
[39] |
Hardy DB, Janowski BA, Corey DR, et al. (2006) Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-κB activation of cyclooxygenase 2 expression. Mol Endocrinol 20: 2724-2733. doi: 10.1210/me.2006-0112
![]() |
[40] |
Arruvito L, Giulianelli S, Flores AC, et al. (2008) NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol 180: 5746-5753. doi: 10.4049/jimmunol.180.8.5746
![]() |
[41] | Piccinni MP, Giudizi MG, Biagiotti R, et al. (1995) Progesterone favors the development of human T helper cells producing TH2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established TH1 cell clones. J Immunol 155: 128-133. |
[42] |
Özdemir BC, Dotto GP (2019) Sex hormones an anticancer immunity. Clin Cancer Res 25: 4603-4610. doi: 10.1158/1078-0432.CCR-19-0137
![]() |
[43] |
Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427. doi: 10.1016/S0140-6736(03)14596-5
![]() |
[44] |
Grady D, Gebretsadik T, Kerlikowske K, et al. (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85: 304-313. doi: 10.1016/0029-7844(94)00383-O
![]() |
[45] |
Lacey JV, Mink PJ, Lubin JH, et al. (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288: 334-341. doi: 10.1001/jama.288.3.334
![]() |
[46] |
Fournier A, Berrino F, Clavel-Chapelon F (2008) Unequal risks for breast cancer associated with different hormone replacement therapies results from the E3N cohort study. Breast Cancer Res Treat 107: 103-111. doi: 10.1007/s10549-007-9523-x
![]() |
[47] |
Anderson GL, Limacher M, Assaf AR, et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701-1712. doi: 10.1001/jama.291.14.1701
![]() |
[48] |
Key TJ, Pike MC (1988) The dose-effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57: 205-212. doi: 10.1038/bjc.1988.44
![]() |
[49] |
Cook MB, Dawsey SM, Freedman ND, et al. (2009) Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 18: 1174-1182. doi: 10.1158/1055-9965.EPI-08-1118
![]() |
[50] |
Cook MB, McGlynn KA, Devesa SS, et al. (2011) Sex disparities in cancer mortality and survival. Cancer Epidemiol. Biomarkers Prev 20: 1629-1637. doi: 10.1158/1055-9965.EPI-11-0246
![]() |
[51] |
Lista P, Straface E, Brunelleschi S, et al. (2011) On the role of autophagy in human diseases: a gender perspective. J Cell Mol Med 15: 1443-1457. doi: 10.1111/j.1582-4934.2011.01293.x
![]() |
[52] |
Lin PY, Sun L, Thibodeaux SR, et al. (2010) B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol 185: 2747-2753. doi: 10.4049/jimmunol.1000496
![]() |
[53] |
Polanczyk MJ, Hopke C, Vandenbark AA, et al. (2006) Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res 84: 370-378. doi: 10.1002/jnr.20881
![]() |
[54] |
Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nature Rev Immunol 16: 626-638. doi: 10.1038/nri.2016.90
![]() |
[55] |
Nance DM, Sanders VM (2007) Autonomic innervation and regulation of the immune system. Brain Behav Immun 21: 736-745. doi: 10.1016/j.bbi.2007.03.008
![]() |
[56] |
Priyanka HP, Pratap UP, Singh RV, et al. (2014) Estrogen modulates β2-adrenoceptor-induced cell-mediated and inflammatory immune responses through ER-α involving distinct intracellular signaling pathways, antioxidant enzymes, and nitric oxide. Cell Immunol 292: 1-8. doi: 10.1016/j.cellimm.2014.08.001
![]() |
[57] |
Priyanka HP, Krishnan HC, Singh RV, et al. (2013) Estrogen modulates in vitro T cell responses in a concentration- and receptor dependent manner: effects on intracellular molecular targets and antioxidant enzymes. Mol Immunol 56: 328-339. doi: 10.1016/j.molimm.2013.05.226
![]() |
[58] |
Pratap UP, Patil A, Sharma HR, et al. (2016) Estrogen-induced neuroprotective and anti-inflammatory effects are dependent on the brain areas of middle-aged female rats. Brain Res Bull 124: 238-253. doi: 10.1016/j.brainresbull.2016.05.015
![]() |
[59] |
Kale P, Mohanty A, Mishra M, et al. (2014) Estrogen modulates neural–immune interactions through intracellular signaling pathways and antioxidant enzyme activity in the spleen of middle-aged ovariectomized female rats. J Neuroimmunol 267: 7-15. doi: 10.1016/j.jneuroim.2013.11.003
![]() |
[60] |
Priyanka HP, Sharma U, Gopinath S, et al. (2013) Menstrual cycle and reproductive aging alters immune reactivity, NGF expression, antioxidant enzyme activities, and intracellular signaling pathways in the peripheral blood mononuclear cells of healthy women. Brain Behav Immun 32: 131-143. doi: 10.1016/j.bbi.2013.03.008
![]() |
[61] |
Ulrich-Lai YM, Herman JP (2009) Neural regulation of endocrine and autoimmune stress responses. Nat Rev Neurosci 10: 397-409. doi: 10.1038/nrn2647
![]() |
[62] |
Herman JP, Flak J, Jankord R (2008) Chronic stress plasticity in the hypothalamic paraventricular nucleus. Prog Brain Res 170: 353-364. doi: 10.1016/S0079-6123(08)00429-9
![]() |
[63] |
Iftikhar A, Islam M, Shepherd S, et al. (2021) Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide? Cancers (Basel) 13: 163. doi: 10.3390/cancers13020163
![]() |
[64] |
Lin KT, Wang LH (2016) New dimension of glucocorticoids in cancer treatment. Steroids 111: 84-88. doi: 10.1016/j.steroids.2016.02.019
![]() |
[65] |
Antoni MH, Lutgendorf SK, Cole SW, et al. (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6: 240-248. doi: 10.1038/nrc1820
![]() |
[66] |
Lutgendorf SK, Costanzo E, Siegel S (2007) Psychosocial influences in oncology: An expanded model of biobehavioral mechanisms. Psychoneuroimmunology New York, NY, USA: Academic Press, 869-895. doi: 10.1016/B978-012088576-3/50048-4
![]() |
[67] |
Xie H, Li B, Li L, et al. (2014) Association of increased circulating catecholamine and glucocorticoid levels with risk of psychological problems in oral neoplasm patients. PLoS One 9: e99179. doi: 10.1371/journal.pone.0099179
![]() |
[68] |
Lutgendorf SK, DeGeest K, Dahmoush L, et al. (2011) Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 25: 250-255. doi: 10.1016/j.bbi.2010.10.012
![]() |
[69] |
Obeid EI, Conzen SD (2013) The role of adrenergic signaling in breast cancer biology. Cancer Biomark 13: 161-169. doi: 10.3233/CBM-130347
![]() |
[70] |
Mravec B, Horvathova L, Hunakova L (2020) Neurobiology of cancer: the role of β-adrenergic receptor signaling in various tumor environments. Int J Mol Sci 21: 7958. doi: 10.3390/ijms21217958
![]() |
[71] |
Thaker PH, Han LY, Kamat AA, et al. (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12: 939-944. doi: 10.1038/nm1447
![]() |
[72] |
Lin Q, Wang F, Yang R, et al. (2013) Effect of chronic restraint stress on human colorectal carcinoma growth in mice. PLoS One 8: e61435. doi: 10.1371/journal.pone.0061435
![]() |
[73] |
Landen CN, Lin YG, Armaiz Pena GN, et al. (2007) Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67: 10389-10396. doi: 10.1158/0008-5472.CAN-07-0858
![]() |
[74] |
Shang ZJ, Liu K, Liang DF (2009) Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med 38: 371-376. doi: 10.1111/j.1600-0714.2008.00691.x
![]() |
[75] |
Saul AN, Oberyszyn TM, Daugherty C, et al. (2005) Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 97: 1760-1767. doi: 10.1093/jnci/dji401
![]() |
[76] |
Ben-Eliyahu S, Page GG, Yirmiya R, et al. (1999) Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80: 880-888. doi: 10.1002/(SICI)1097-0215(19990315)80:6<880::AID-IJC14>3.0.CO;2-Y
![]() |
[77] |
Ben-Eliyahu S, Yirmiya R, Liebeskind JC, et al. (1991) Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 5: 193-205. doi: 10.1016/0889-1591(91)90016-4
![]() |
[78] |
Greenfeld K, Avraham R, Benish M, et al. (2007) Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav Immun 21: 503-513. doi: 10.1016/j.bbi.2006.12.006
![]() |
[79] |
Morris N, Moghaddam N, Tickle A, et al. (2018) The relationship between coping style and psychological distress in people with head and neck cancer: A systematic review. Psychooncology 27: 734-747. doi: 10.1002/pon.4509
![]() |
[80] | Nogueira TE, Adorno M, Mendonça E, et al. (2018) Factors associated with the quality of life of subjects with facial disfigurement due to surgical treatment of head and neck cancer. Med Oral Patol Oral Cir Bucal 23: e132-e137. |
[81] |
Hagedoorn M, Molleman E (2006) Facial disfigurement in patients with head and neck cancer: the role of social self-efficacy. Health Psychol 25: 643-647. doi: 10.1037/0278-6133.25.5.643
![]() |
[82] |
Lackovicova L, Gaykema RP, Banovska L, et al. (2013) The time-course of hindbrain neuronal activity varies according to location during either intraperitoneal or subcutaneous tumor growth in rats: Single Fos and dual Fos/dopamine beta-hydroxylase immunohistochemistry. J Neuroimmunol 260: 37-46. doi: 10.1016/j.jneuroim.2013.04.010
![]() |
[83] |
Horvathova L, Tillinger A, Padova A, et al. (2020) Changes in gene expression in brain structures related to visceral sensation, autonomic functions, food intake, and cognition in melanoma-bearing mice. Eur J Neurosci 51: 2376-2393. doi: 10.1111/ejn.14661
![]() |
[84] |
Kin NW, Sanders VM (2006) It takes nerve to tell T and B cells what to do. J Leukocyte Biol 79: 1093-1104. doi: 10.1189/jlb.1105625
![]() |
[85] |
Straub RH (2004) Complexity of the bi-directional neuroimmune junction in the spleen. Trends Pharmacol Sci 25: 640-646. doi: 10.1016/j.tips.2004.10.007
![]() |
[86] |
Nance DM, Sanders VM (2007) Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav Immun 21: 736-745. doi: 10.1016/j.bbi.2007.03.008
![]() |
[87] |
Madden KS (2003) Catecholamines, sympathetic innervation, and immunity. Brain Behav Immun 17: S5-10. doi: 10.1016/S0889-1591(02)00059-4
![]() |
[88] |
ThyagaRajan S, Felten DL (2002) Modulation of neuroendocrine--immune signaling by L-deprenyl and L-desmethyldeprenyl in aging and mammary cancer. Mech Ageing Dev 123: 1065-1079. doi: 10.1016/S0047-6374(01)00390-6
![]() |
[89] |
Pratap U, Hima L, Kannan T, et al. (2020) Sex-Based Differences in the Cytokine Production and Intracellular Signaling Pathways in Patients With Rheumatoid Arthritis. Arch Rheumatol 35: 545-557. doi: 10.46497/ArchRheumatol.2020.7481
![]() |
[90] |
Hima L, Patel M, Kannan T, et al. (2020) Age-associated decline in neural, endocrine, and immune responses in men and women: Involvement of intracellular signaling pathways. J Neuroimmunol 345: 577290. doi: 10.1016/j.jneuroim.2020.577290
![]() |
[91] |
Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39: 1-10. doi: 10.1016/j.immuni.2013.07.012
![]() |
[92] |
Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331: 1565-1570. doi: 10.1126/science.1203486
![]() |
[93] |
Sanders VM (1995) The role of adrenoceptor-mediated signals in the modulation of lymphocyte function. Adv Neuroimmunol 5: 283-298. doi: 10.1016/0960-5428(95)00019-X
![]() |
[94] |
Madden KS, Felten DL (1995) Experimental basis for neural-immune interactions. Physiol Rev 75: 77-106. doi: 10.1152/physrev.1995.75.1.77
![]() |
[95] |
Madden KS (2003) Catecholamines, sympathetic innervation, and immunity. Brain Behav Immun 17: S5-10. doi: 10.1016/S0889-1591(02)00059-4
![]() |
[96] |
Callahan TA, Moynihan JA (2002) The effects of chemical sympathectomy on T-cell cytokine responses are not mediated by altered peritoneal exudate cell function or an inflammatory response. Brain Behav Immun 16: 33-45. doi: 10.1006/brbi.2000.0618
![]() |
[97] |
Madden KS, Felten SY, Felten DL, et al. (1989) Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy. Brain Behav Immun 3: 72-89. doi: 10.1016/0889-1591(89)90007-X
![]() |
[98] |
Alaniz RC, Thomas SA, Perez-Melgosa M, et al. (1999) Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci U S A 96: 2274-2278. doi: 10.1073/pnas.96.5.2274
![]() |
[99] |
Pongratz G, McAlees JW, Conrad DH, et al. (2006) The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J Immunol 177: 2926-2938. doi: 10.4049/jimmunol.177.5.2926
![]() |
[100] |
Chen F, Zhuang X, Lin L, et al. (2015) New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13: 45. doi: 10.1186/s12916-015-0278-7
![]() |
[101] |
Wang M, Zhao J, Zhang L, et al. (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8: 761-773. doi: 10.7150/jca.17648
![]() |
[102] |
Del Prete A, Schioppa T, Tiberio L, et al. (2017) Leukocyte trafficking in tumor microenvironment. Curr Opin Pharmacol 35: 40-47. doi: 10.1016/j.coph.2017.05.004
![]() |
[103] |
Jiang Y, Li Y, Zhu B (2015) T-cell exhaustion in the tumor microenvironment. Cell Death Dis 6: e1792. doi: 10.1038/cddis.2015.162
![]() |
[104] |
Maimela NR, Liu S, Zhang Y (2019) Fates of CD8+ T cells in tumor microenvironment. Comput Struct Biotechnol J 17: 1-13. doi: 10.1016/j.csbj.2018.11.004
![]() |
[105] |
Zhang Z, Liu S, Zhang B, et al. (2020) T Cell Dysfunction and Exhaustion in Cancer. Front Cell Dev Biol 8: 17. doi: 10.3389/fcell.2020.00017
![]() |
[106] |
Gonzalez H, Robles I, Werb Z (2018) Innate and acquired immune surveillance in the postdissemination phase of metastasis. FEBS J 285: 654-664. doi: 10.1111/febs.14325
![]() |
[107] |
Komohara Y, Fujiwara Y, Ohnishi K, et al. (2016) Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy. Adv Drug Delivery Rev 99: 180-185. doi: 10.1016/j.addr.2015.11.009
![]() |
[108] |
Mantovani A, Marchesi F, Malesci A, et al. (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14: 399-416. doi: 10.1038/nrclinonc.2016.217
![]() |
[109] |
Linde N, Lederle W, Depner S, et al. (2012) Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. J Pathol 227: 17-28. doi: 10.1002/path.3989
![]() |
[110] |
Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105: 1-8. doi: 10.1111/cas.12314
![]() |
[111] |
Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27: 462-472. doi: 10.1016/j.ccell.2015.02.015
![]() |
[112] |
Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41: 49-61. doi: 10.1016/j.immuni.2014.06.010
![]() |
[113] |
Long KB, Gladney WL, Tooker GM, et al. (2016) IFN-γ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma. Cancer Discov 6: 400-413. doi: 10.1158/2159-8290.CD-15-1032
![]() |
[114] |
Muz B, de la Puente P, Azab F, et al. (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl) 3: 83-92. doi: 10.2147/HP.S93413
![]() |
[115] |
Zhang CC, Sadek HA (2014) Hypoxia and metabolic properties of hematopoietic stem cells. Antioxid Redox Signal 20: 1891-1901. doi: 10.1089/ars.2012.5019
![]() |
[116] |
Henze AT, Mazzone M (2016) The impact of hypoxia on tumor-associated macrophages. J Clin Invest 126: 3672-3679. doi: 10.1172/JCI84427
![]() |
[117] |
Chen P, Zuo H, Xiong H, et al. (2017) Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc Natl Acad Sci 114: 580-585. doi: 10.1073/pnas.1614035114
![]() |
[118] |
Albo D, Akay CL, Marshall CL, et al. (2011) Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer 117: 4834-4845. doi: 10.1002/cncr.26117
![]() |
[119] |
Kamiya A, Hiyama T, Fujimura A, et al. (2021) Sympathetic and parasympathetic innervation in cancer: therapeutic implications. Clin Auton Res 31: 165-178. doi: 10.1007/s10286-020-00724-y
![]() |
[120] |
Ceyhan GO, Schäfer KH, Kerscher AG, et al. (2010) Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann Surg 251: 923-931. doi: 10.1097/SLA.0b013e3181d974d4
![]() |
[121] |
Zhao CM, Hayakawa Y, Kodama Y, et al. (2014) Denervation suppresses gastric tumorigenesis. Sci Transl Med 6: 250ra115. doi: 10.1126/scitranslmed.3009569
![]() |
[122] |
Liebig C, Ayala G, Wilks JA, et al. (2009) Perineural invasion in cancer: a review of the literature. Cancer 115: 3379-3391. doi: 10.1002/cncr.24396
![]() |
[123] |
Dai H, Li R, Wheeler T, et al. (2007) Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol 38: 299-307. doi: 10.1016/j.humpath.2006.08.002
![]() |
[124] |
Liebig C, Ayala G, Wilks J, et al. (2009) Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27: 5131-5137. doi: 10.1200/JCO.2009.22.4949
![]() |
[125] |
Conceição F, Sousa DM, Paredes J, et al. (2021) Sympathetic activity in breast cancer and metastasis: partners in crime. Bone Res 9: 9. doi: 10.1038/s41413-021-00137-1
![]() |
[126] |
Mauffrey P, Tchitchek N, Barroca V, et al. (2019) Progenitors from the central nervous system drive neurogenesis in cancer. Nature 569: 672-678. doi: 10.1038/s41586-019-1219-y
![]() |
[127] |
Ruscica M, Dozio E, Motta M, et al. (2007) Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer. Peptides 28: 426-434. doi: 10.1016/j.peptides.2006.08.045
![]() |
[128] |
Hayakawa Y, Sakitani K, Konishi M, et al. (2017) Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling. Cancer Cell 31: 21-34. doi: 10.1016/j.ccell.2016.11.005
![]() |
[129] |
Barabutis N (2021) Growth Hormone Releasing Hormone in Endothelial Barrier Function. Trends Endocrinol Metab 32: 338-340. doi: 10.1016/j.tem.2021.03.001
![]() |
[130] |
ThyagaRajan S, Madden KS, Kalvass JC, et al. (1998) L-deprenyl-induced increase in IL-2 and NK cell activity accompanies restoration of noradrenergic nerve fibers in the spleens of old F344 rats. J Neuroimmunol 92: 9-21. doi: 10.1016/S0165-5728(98)00039-3
![]() |
[131] |
Zumoff B (1998) Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy. Proc Soc Exp Biol Med 217: 30-37. doi: 10.3181/00379727-217-44202
![]() |
[132] |
Hollingsworth AB, Lerner MR, Lightfoot SA, et al. (1998) Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen. Breast Cancer Res Treat 47: 63-70. doi: 10.1023/A:1005872132373
![]() |
[133] |
Sun G, Wu L, Sun G, et al. (2021) WNT5a in Colorectal Cancer: Research Progress and Challenges. Cancer Manag Res 13: 2483-2498. doi: 10.2147/CMAR.S289819
![]() |
[134] |
Schlange T, Matsuda Y, Lienhard S, et al. (2007) Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 9: R63. doi: 10.1186/bcr1769
![]() |
[135] |
Sun X, Bernhardt SM, Glynn DJ, et al. (2021) Attenuated TGFB signalling in macrophages decreases susceptibility to DMBA-induced mammary cancer in mice. Breast Cancer Res 23: 39. doi: 10.1186/s13058-021-01417-8
![]() |
[136] |
Heasley L (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 20: 1563-1569. doi: 10.1038/sj.onc.1204183
![]() |
[137] |
Cuttitta F, Carney DN, Mulshine J, et al. (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823-826. doi: 10.1038/316823a0
![]() |
[138] |
Moody TW, Pert CB, Gazdar AF, et al. (1981) Neurotensin is produced by and secreted from classic small cell lung cancer cells. Science 214: 1246-1248. doi: 10.1126/science.6272398
![]() |
[139] | Cardona C, Rabbitts PH, Spindel ER, et al. (1991) Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines. Cancer Res 51: 5205-5211. |
[140] |
Sun B, Halmos G, Schally AV, et al. (2000) Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate 42: 295-303. doi: 10.1002/(SICI)1097-0045(20000301)42:4<295::AID-PROS7>3.0.CO;2-B
![]() |
[141] | Markwalder R, Reubi JC (1999) Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 59: 1152-1159. |
[142] |
Moody TW, Pert CB, Gazdar AF, et al. (1981) Neurotensin is produced by and secreted from classic small cell lung cancer cells. Science 214: 1246-1248. doi: 10.1126/science.6272398
![]() |
[143] |
Goetze JP, Nielsen FC, Burcharth F, et al. (2000) Closing the gastrin loop in pancreatic carcinoma: Co-expression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer 88: 2487-2494. doi: 10.1002/1097-0142(20000601)88:11<2487::AID-CNCR9>3.0.CO;2-E
![]() |
[144] |
Blackmore M, Hirst B (1992) Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br J Cancer 66: 32-38. doi: 10.1038/bjc.1992.212
![]() |
[145] | Smith JP, Liu G, Soundararajan V, et al. (1994) Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol 266: R277-283. |
[146] |
Seethalakshmi L, Mitra SP, Dobner PR, et al. (1997) Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate 31: 183-192. doi: 10.1002/(SICI)1097-0045(19970515)31:3<183::AID-PROS7>3.0.CO;2-M
![]() |
[147] |
Kawaguchi K, Sakurai M, Yamamoto Y, et al. (2019) Alteration of specific cytokine expression patterns in patients with breast cancer. Sci Rep 9: 2924. doi: 10.1038/s41598-019-39476-9
![]() |
[148] |
Smyth MJ, Cretney E, Kershaw MH, et al. (2004) Cytokines in cancer immunity and immunotherapy. Immunol Rev 202: 275-293. doi: 10.1111/j.0105-2896.2004.00199.x
![]() |
[149] |
Wang X, Lin Y (2008) Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 29: 1275-1288. doi: 10.1111/j.1745-7254.2008.00889.x
![]() |
[150] |
Ohri CM, Shikotra A, Green RH, et al. (2010) Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer. BMC Cancer 10: 323. doi: 10.1186/1471-2407-10-323
![]() |
[151] |
Woo CH, Eom YW, Yoo MH, et al. (2000) Tumor necrosis factor-α generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 275: 32357-32362. doi: 10.1074/jbc.M005638200
![]() |
[152] |
Suganuma M, Watanabe T, Yamaguchi K, et al. (2012) Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori. Cancer Lett 322: 133-138. doi: 10.1016/j.canlet.2012.03.027
![]() |
[153] |
Cai X, Cao C, Li J, et al. (2017) Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1. Oncotarget 8: 58338-58352. doi: 10.18632/oncotarget.16873
![]() |
[154] |
Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095. doi: 10.1084/jem.170.6.2081
![]() |
[155] |
Ikeguchi M, Hatada T, Yamamoto M, et al. (2009) Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer 12: 95-100. doi: 10.1007/s10120-009-0509-8
![]() |
[156] |
Hassuneh MR, Nagarkatti M, Nagarkatti PS (2013) Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma. Leuk Lymphoma 54: 827-834. doi: 10.3109/10428194.2012.726721
![]() |
[157] |
Hodge DR, Hurt EM, Farrar WL (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41: 2502-2512. doi: 10.1016/j.ejca.2005.08.016
![]() |
[158] |
Kim SY, Kang JW, Song X, et al. (2013) Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells. Cell Signaling 25: 961-969. doi: 10.1016/j.cellsig.2013.01.007
![]() |
[159] |
Mravec B, Horvathova L, Cernackova A (2019) Hypothalamic Inflammation at a Crossroad of Somatic Diseases. Cell Mol Neurobiol 39: 11-29. doi: 10.1007/s10571-018-0631-4
![]() |
[160] |
Morrison CD, Parvani JG, Schiemann WP (2013) The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett 341: 30-40. doi: 10.1016/j.canlet.2013.02.048
![]() |
[161] |
Bierie B, Moses HL (2006) TGF-β and cancer. Cytokine Growth Factor Rev 17: 29-40. doi: 10.1016/j.cytogfr.2005.09.006
![]() |
[162] |
Levy L, Hill CS (2006) Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17: 41-58. doi: 10.1016/j.cytogfr.2005.09.009
![]() |
1. | Adindra Vickar Ega, Eka Firmansyah, Dzuhri Radityo Utomo, Jayan Sentanuhady, Gigin Ginanjar, Sugeng Haryadi, 2022, 2664, 0094-243X, 030003, 10.1063/5.0108069 | |
2. | Michel Fliess, Cédric Join, Alberto d'Onofrio, Feedback control of social distancing for COVID-19 via elementary formulae, 2022, 55, 24058963, 439, 10.1016/j.ifacol.2022.09.134 | |
3. | Cong Toai Truong, Kim Hieu Huynh, Van Tu Duong, Huy Hung Nguyen, Le An Pham, Tan Tien Nguyen, Linear regression model and least square method for experimental identification of AMBU bag in simple ventilator, 2022, 2049-6427, 10.1108/IJIUS-07-2021-0072 | |
4. | Cédric Join, Alberto d’Onofrio, Michel Fliess, Toward More Realistic Social Distancing Policies via Advanced Feedback Control, 2022, 3, 2673-4052, 286, 10.3390/automation3020015 | |
5. | Michel Fliess, Cédric Join, Kaouther Moussa, Seddik M. Djouadi, Mohamed W. Alsager, Toward simple in silico experiments for drugs administration in some cancer treatments, 2021, 54, 24058963, 245, 10.1016/j.ifacol.2021.10.263 | |
6. | Ardian Ulvan, , 2022, 2563, 0094-243X, 030001, 10.1063/5.0110571 | |
7. | Cong Toai Truong, Danh Khoa Nguyen, Ngoc Quy Tran, Van Tu Duong, Huy Hung Nguyen, Tan Tien Nguyen, 2024, Chapter 77, 978-3-031-44629-0, 969, 10.1007/978-3-031-44630-6_77 | |
8. | Van Tu Duong, Anh Tuan Vo Tran, Quoc Dan Le, Huy Hung Nguyen, Sang Bong Kim, Tan Tien Nguyen, 2024, Chapter 2, 978-981-99-8702-3, 15, 10.1007/978-981-99-8703-0_2 | |
9. | Danh Khoa Nguyen, Cong Toai Truong, Van Tu Duong, Huy Hung Nguyen, Tan Tien Nguyen, [ICACE2022] Model identification of two double-acting pistons pump, 2023, 47, 2234-7925, 59, 10.5916/jamet.2023.47.2.59 | |
10. | Van Tu Duong, Cong Toai Truong, Trong Trung Nguyen, Huy Hung Nguyen, Tan Tien Nguyen, State space model identification using model reference adaptive approach: software and hardware-in-the-loop simulation, 2024, 11, 2331-1916, 10.1080/23311916.2024.2434938 | |
11. | Cédric Join, D. Blair Jovellar, Emmanuel Delaleau, Michel Fliess, 2024, Detection and Suppression of Epileptiform Seizures via Model-Free Control and Derivatives in a Noisy Environment, 979-8-3315-3181-2, 79, 10.1109/ICSC63929.2024.10928959 |